<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Med</journal-id><journal-id journal-id-type="iso-abbrev">Front Med</journal-id><journal-id journal-id-type="pmc-domain-id">3814</journal-id><journal-id journal-id-type="pmc-domain">phenaturepg</journal-id><journal-title-group><journal-title>Frontiers of Medicine</journal-title></journal-title-group><issn pub-type="ppub">2095-0217</issn><issn pub-type="epub">2095-0225</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer Nature - PMC COVID-19 Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC8815389</article-id><article-id pub-id-type="pmcid-ver">PMC8815389.1</article-id><article-id pub-id-type="pmcaid">8815389</article-id><article-id pub-id-type="pmcaiid">8815389</article-id><article-id pub-id-type="pmid">35122210</article-id><article-id pub-id-type="doi">10.1007/s11684-021-0893-y</article-id><article-id pub-id-type="publisher-id">893</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>A review of the safety and efficacy of current COVID-19 vaccines</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="Z">Zehong</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Su</surname><given-names initials="Y">Yingying</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="T">Tianying</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Xia</surname><given-names initials="N">Ningshao</given-names></name><address><email>nsxia@xmu.edu.cn</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.12955.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2264 7233</institution-id><institution>State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, </institution><institution>Xiamen University, </institution></institution-wrap>Xiamen, 361102 China </aff></contrib-group><pub-date pub-type="epub"><day>3</day><month>2</month><year>2022</year></pub-date><pub-date pub-type="ppub"><year>2022</year></pub-date><volume>16</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">400157</issue-id><fpage>39</fpage><lpage>55</lpage><history><date date-type="received"><day>30</day><month>5</month><year>2021</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>04</day><month>02</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>07</day><month>02</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2022-10-25 00:10:16.223"><day>25</day><month>10</month><year>2022</year></date></event></pub-history><permissions><copyright-statement>&#169; Higher Education Press 2022</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="11684_2021_Article_893.pdf"/><abstract id="Abs1"><p>Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019 (COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an extraordinary achievement. This study reviewed the efficacy/effectiveness, immunogenicity, and safety profile of the 12 most progressed COVID-19 vaccines and discussed the challenges and prospects of the vaccine-based approaches in a global crisis. Overall, most of the current vaccines have shown safety and efficacy/effectiveness during actual clinical trials or in the real-world studies, indicating a development of pandemic control. However, many challenges are faced by pandemic control in terms of maximizing the effect of vaccines, such as rapid vaccine coverage, strategies to address variants with immune escape capability, and surveillance of vaccine safety in the medium- and long-terms.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>vaccine</kwd><kwd>safety</kwd><kwd>efficacy</kwd><kwd>effectiveness</kwd><kwd>immunogenicity</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature 2022</meta-value></custom-meta></custom-meta-group></article-meta></front><back><fn-group><fn><p><bold>Compliance with ethics guidelines</bold></p><p>Zehong Huang, Yingying Su, Tianying Zhang, and Ningshao Xia declare that they have no conflict of interest. This manuscript is a review article and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was supported by the National Natural Science Foundation of China (No. 81991491), the Fujian Natural Science Foundation for Distinguished Young Scholars (No. 2020J06007), and the Bill and Melinda Gates Foundation (No. INV-005834).</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">World Health Organization. WHO coronavirus disease (COVID-19) dashboard. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://covid19.who.int/">https://covid19.who.int/</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spinelli</surname><given-names>MA</given-names></name><name name-style="western"><surname>Glidden</surname><given-names>DV</given-names></name><name name-style="western"><surname>Gennatas</surname><given-names>ED</given-names></name><name name-style="western"><surname>Bielecki</surname><given-names>M</given-names></name><name name-style="western"><surname>Beyrer</surname><given-names>C</given-names></name><name name-style="western"><surname>Rutherford</surname><given-names>G</given-names></name><name name-style="western"><surname>Chambers</surname><given-names>H</given-names></name><name name-style="western"><surname>Goosby</surname><given-names>E</given-names></name><name name-style="western"><surname>Gandhi</surname><given-names>M</given-names></name></person-group><article-title>Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity</article-title><source>Lancet Infect Dis</source><year>2021</year><volume>21</volume><issue>9</issue><fpage>e296</fpage><lpage>e301</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30982-8</pub-id><pub-id pub-id-type="pmid">33631099</pub-id><pub-id pub-id-type="pmcid">PMC7906703</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">World Health Organization. Draft landscape of COVID-19 candidate vaccines. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines/">https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines/</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">National Medical Products Administration. Vaccine gets conditional approval for general use. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://subsites.chinadaily.com.cn/nmpa/2021-01/04/c_579626.htm">http://subsites.chinadaily.com.cn/nmpa/2021-01/04/c_579626.htm</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Sinovac. Sinovac receives conditional marketing authorization in China for its COVID-19 vaccine. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sinovac.com.cn/news/shownews.php?id=1153&amp;lang=en">http://www.sinovac.com.cn/news/shownews.php?id=1153&amp;lang=en</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">National Medical Products Administration. NMPA conditionally approves COVID-19 vaccine developed by Sinopharm&#8217;s Wuhan Institute. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://subsites.chinadaily.com.cn/nmpa/2021-02/27/c_597152.htm">http://subsites.chinadaily.com.cn/nmpa/2021-02/27/c_597152.htm</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">CanSinoBIO. NMPA accepts the application for conditional marketing authorization of CanSinoBIO&#8217;s COVID-19 vaccine Convidecia&#8482;. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.cansinotech.com/html/1///179/180/651.html">http://www.cansinotech.com/html/1///179/180/651.html</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">U.S. Food and Drug Administration. Emergency use authorization. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#vaccines">https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#vaccines</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Medicines and Healthcare products Regulatory Agency. Regulatory approval of COVID-19 vaccine AstraZeneca. 2020. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca">https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Milken Institute. Vaccines in use. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.covid-19vaccinetracker.org/authorized-vaccines">https://www.covid-19vaccinetracker.org/authorized-vaccines</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Ministry of Health and Family Welfare, Government of India. Frequently asked questions&#8212;about the vaccine. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.mohfw.gov.in/covid_vaccination/vaccination/faqs.html#vaccine-registration">https://www.mohfw.gov.in/covid_vaccination/vaccination/faqs.html#vaccine-registration</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">World Health Organization. Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_15-July2021.pdf">https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_15-July2021.pdf</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">World Health Organization. WHO target product profiles for COVID-19 vaccines. 2020. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/publications/m/item/who-target-product-profiles-for-covid-19-vaccines/">https://www.who.int/publications/m/item/who-target-product-profiles-for-covid-19-vaccines/</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baden</surname><given-names>LR</given-names></name><name name-style="western"><surname>El Sahly</surname><given-names>HM</given-names></name><name name-style="western"><surname>Essink</surname><given-names>B</given-names></name><name name-style="western"><surname>Kotloff</surname><given-names>K</given-names></name><name name-style="western"><surname>Frey</surname><given-names>S</given-names></name><name name-style="western"><surname>Novak</surname><given-names>R</given-names></name><name name-style="western"><surname>Diemert</surname><given-names>D</given-names></name><name name-style="western"><surname>Spector</surname><given-names>SA</given-names></name><name name-style="western"><surname>Rouphael</surname><given-names>N</given-names></name><name name-style="western"><surname>Creech</surname><given-names>CB</given-names></name><name name-style="western"><surname>McGettigan</surname><given-names>J</given-names></name><name name-style="western"><surname>Khetan</surname><given-names>S</given-names></name><name name-style="western"><surname>Segall</surname><given-names>N</given-names></name><name name-style="western"><surname>Solis</surname><given-names>J</given-names></name><name name-style="western"><surname>Brosz</surname><given-names>A</given-names></name><name name-style="western"><surname>Fierro</surname><given-names>C</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>H</given-names></name><name name-style="western"><surname>Neuzil</surname><given-names>K</given-names></name><name name-style="western"><surname>Corey</surname><given-names>L</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>P</given-names></name><name name-style="western"><surname>Janes</surname><given-names>H</given-names></name><name name-style="western"><surname>Follmann</surname><given-names>D</given-names></name><name name-style="western"><surname>Marovich</surname><given-names>M</given-names></name><name name-style="western"><surname>Mascola</surname><given-names>J</given-names></name><name name-style="western"><surname>Polakowski</surname><given-names>L</given-names></name><name name-style="western"><surname>Ledgerwood</surname><given-names>J</given-names></name><name name-style="western"><surname>Graham</surname><given-names>BS</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>H</given-names></name><name name-style="western"><surname>Pajon</surname><given-names>R</given-names></name><name name-style="western"><surname>Knightly</surname><given-names>C</given-names></name><name name-style="western"><surname>Leav</surname><given-names>B</given-names></name><name name-style="western"><surname>Deng</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Han</surname><given-names>S</given-names></name><name name-style="western"><surname>Ivarsson</surname><given-names>M</given-names></name><name name-style="western"><surname>Miller</surname><given-names>J</given-names></name><name name-style="western"><surname>Zaks</surname><given-names>T</given-names></name><collab>the COVE Study Group</collab></person-group><article-title>Efficacy and Safety of the mRNA-1273 SARS-CoV-2 vaccine</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>5</issue><fpage>403</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2035389</pub-id><pub-id pub-id-type="pmid">33378609</pub-id><pub-id pub-id-type="pmcid">PMC7787219</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Polack</surname><given-names>FP</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kitchin</surname><given-names>N</given-names></name><name name-style="western"><surname>Absalon</surname><given-names>J</given-names></name><name name-style="western"><surname>Gurtman</surname><given-names>A</given-names></name><name name-style="western"><surname>Lockhart</surname><given-names>S</given-names></name><name name-style="western"><surname>Perez</surname><given-names>JL</given-names></name><name name-style="western"><surname>P&#233;rez Marc</surname><given-names>G</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>ED</given-names></name><name name-style="western"><surname>Zerbini</surname><given-names>C</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>R</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>KA</given-names></name><name name-style="western"><surname>Roychoudhury</surname><given-names>S</given-names></name><name name-style="western"><surname>Koury</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Kalina</surname><given-names>WV</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>D</given-names></name><name name-style="western"><surname>Frenck</surname><given-names>RW</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Hammitt</surname><given-names>LL</given-names></name><name name-style="western"><surname>T&#252;reci</surname><given-names>&#214;</given-names></name><name name-style="western"><surname>Nell</surname><given-names>H</given-names></name><name name-style="western"><surname>Schaefer</surname><given-names>A</given-names></name><name name-style="western"><surname>&#220;nal</surname><given-names>S</given-names></name><name name-style="western"><surname>Tresnan</surname><given-names>DB</given-names></name><name name-style="western"><surname>Mather</surname><given-names>S</given-names></name><name name-style="western"><surname>Dormitzer</surname><given-names>PR</given-names></name><name name-style="western"><surname>&#350;ahin</surname><given-names>U</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>KU</given-names></name><name name-style="western"><surname>Gruber</surname><given-names>WC</given-names></name><collab>the C4591001 Clinical Trial Group</collab></person-group><article-title>Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><issue>27</issue><fpage>2603</fpage><lpage>2615</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2034577</pub-id><pub-id pub-id-type="pmid">33301246</pub-id><pub-id pub-id-type="pmcid">PMC7745181</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">CureVac. CureVac: final analysis of pivotal phase 2b/3 HERALD Study. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.curevac.com/wp-content/uploads/2021/07/20210107_CureVac_Final-Analysis-of-Pivotal-Phase-2b-3_Presentation_FINAL.pdf">https://www.curevac.com/wp-content/uploads/2021/07/20210107_CureVac_Final-Analysis-of-Pivotal-Phase-2b-3_Presentation_FINAL.pdf</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Logunov</surname><given-names>DY</given-names></name><name name-style="western"><surname>Dolzhikova</surname><given-names>IV</given-names></name><name name-style="western"><surname>Shcheblyakov</surname><given-names>DV</given-names></name><name name-style="western"><surname>Tukhvatulin</surname><given-names>AI</given-names></name><name name-style="western"><surname>Zubkova</surname><given-names>OV</given-names></name><name name-style="western"><surname>Dzharullaeva</surname><given-names>AS</given-names></name><name name-style="western"><surname>Kovyrshina</surname><given-names>AV</given-names></name><name name-style="western"><surname>Lubenets</surname><given-names>NL</given-names></name><name name-style="western"><surname>Grousova</surname><given-names>DM</given-names></name><name name-style="western"><surname>Erokhova</surname><given-names>AS</given-names></name><name name-style="western"><surname>Botikov</surname><given-names>AG</given-names></name><name name-style="western"><surname>Izhaeva</surname><given-names>FM</given-names></name><name name-style="western"><surname>Popova</surname><given-names>O</given-names></name><name name-style="western"><surname>Ozharovskaya</surname><given-names>TA</given-names></name><name name-style="western"><surname>Esmagambetov</surname><given-names>IB</given-names></name><name name-style="western"><surname>Favorskaya</surname><given-names>IA</given-names></name><name name-style="western"><surname>Zrelkin</surname><given-names>DI</given-names></name><name name-style="western"><surname>Voronina</surname><given-names>DV</given-names></name><name name-style="western"><surname>Shcherbinin</surname><given-names>DN</given-names></name><name name-style="western"><surname>Semikhin</surname><given-names>AS</given-names></name><name name-style="western"><surname>Simakova</surname><given-names>YV</given-names></name><name name-style="western"><surname>Tokarskaya</surname><given-names>EA</given-names></name><name name-style="western"><surname>Egorova</surname><given-names>DA</given-names></name><name name-style="western"><surname>Shmarov</surname><given-names>MM</given-names></name><name name-style="western"><surname>Nikitenko</surname><given-names>NA</given-names></name><name name-style="western"><surname>Gushchin</surname><given-names>VA</given-names></name><name name-style="western"><surname>Smolyarchuk</surname><given-names>EA</given-names></name><name name-style="western"><surname>Zyryanov</surname><given-names>SK</given-names></name><name name-style="western"><surname>Borisevich</surname><given-names>SV</given-names></name><name name-style="western"><surname>Naroditsky</surname><given-names>BS</given-names></name><name name-style="western"><surname>Gintsburg</surname><given-names>AL</given-names></name><collab>Gam-COVID-Vac Vaccine Trial Group</collab></person-group><article-title>Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia</article-title><source>Lancet</source><year>2021</year><volume>397</volume><issue>10275</issue><fpage>671</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00234-8</pub-id><pub-id pub-id-type="pmid">33545094</pub-id><pub-id pub-id-type="pmcid">PMC7852454</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voysey</surname><given-names>M</given-names></name><name name-style="western"><surname>Clemens</surname><given-names>SAC</given-names></name><name name-style="western"><surname>Madhi</surname><given-names>SA</given-names></name><name name-style="western"><surname>Weckx</surname><given-names>LY</given-names></name><name name-style="western"><surname>Folegatti</surname><given-names>PM</given-names></name><name name-style="western"><surname>Aley</surname><given-names>PK</given-names></name><name name-style="western"><surname>Angus</surname><given-names>B</given-names></name><name name-style="western"><surname>Baillie</surname><given-names>VL</given-names></name><name name-style="western"><surname>Barnabas</surname><given-names>SL</given-names></name><name name-style="western"><surname>Bhorat</surname><given-names>QE</given-names></name><name name-style="western"><surname>Bibi</surname><given-names>S</given-names></name><name name-style="western"><surname>Briner</surname><given-names>C</given-names></name><name name-style="western"><surname>Cicconi</surname><given-names>P</given-names></name><name name-style="western"><surname>Collins</surname><given-names>AM</given-names></name><name name-style="western"><surname>Colin-Jones</surname><given-names>R</given-names></name><name name-style="western"><surname>Cutland</surname><given-names>CL</given-names></name><name name-style="western"><surname>Darton</surname><given-names>TC</given-names></name><name name-style="western"><surname>Dheda</surname><given-names>K</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>CJA</given-names></name><name name-style="western"><surname>Emary</surname><given-names>KRW</given-names></name><name name-style="western"><surname>Ewer</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Fairlie</surname><given-names>L</given-names></name><name name-style="western"><surname>Faust</surname><given-names>SN</given-names></name><name name-style="western"><surname>Feng</surname><given-names>S</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>DM</given-names></name><name name-style="western"><surname>Finn</surname><given-names>A</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>AL</given-names></name><name name-style="western"><surname>Green</surname><given-names>CM</given-names></name><name name-style="western"><surname>Green</surname><given-names>CA</given-names></name><name name-style="western"><surname>Heath</surname><given-names>PT</given-names></name><name name-style="western"><surname>Hill</surname><given-names>C</given-names></name><name name-style="western"><surname>Hill</surname><given-names>H</given-names></name><name name-style="western"><surname>Hirsch</surname><given-names>I</given-names></name><name name-style="western"><surname>Hodgson</surname><given-names>SHC</given-names></name><name name-style="western"><surname>Izu</surname><given-names>A</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>S</given-names></name><name name-style="western"><surname>Jenkin</surname><given-names>D</given-names></name><name name-style="western"><surname>Joe</surname><given-names>CCD</given-names></name><name name-style="western"><surname>Kerridge</surname><given-names>S</given-names></name><name name-style="western"><surname>Koen</surname><given-names>A</given-names></name><name name-style="western"><surname>Kwatra</surname><given-names>G</given-names></name><name name-style="western"><surname>Lazarus</surname><given-names>R</given-names></name><name name-style="western"><surname>Lawrie</surname><given-names>AM</given-names></name><name name-style="western"><surname>Lelliott</surname><given-names>A</given-names></name><name name-style="western"><surname>Libri</surname><given-names>V</given-names></name><name name-style="western"><surname>Lillie</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Mallory</surname><given-names>R</given-names></name><name name-style="western"><surname>Mendes</surname><given-names>AVA</given-names></name><name name-style="western"><surname>Milan</surname><given-names>EP</given-names></name><name name-style="western"><surname>Minassian</surname><given-names>AM</given-names></name><name name-style="western"><surname>McGregor</surname><given-names>A</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>H</given-names></name><name name-style="western"><surname>Mujadidi</surname><given-names>YF</given-names></name><name name-style="western"><surname>Nana</surname><given-names>A</given-names></name><name name-style="western"><surname>O&#8217;Reilly</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Padayachee</surname><given-names>SD</given-names></name><name name-style="western"><surname>Pittella</surname><given-names>A</given-names></name><name name-style="western"><surname>Plested</surname><given-names>E</given-names></name><name name-style="western"><surname>Pollock</surname><given-names>KM</given-names></name><name name-style="western"><surname>Ramasamy</surname><given-names>MN</given-names></name><name name-style="western"><surname>Rhead</surname><given-names>S</given-names></name><name name-style="western"><surname>Schwarzbold</surname><given-names>AV</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>Song</surname><given-names>R</given-names></name><name name-style="western"><surname>Snape</surname><given-names>MD</given-names></name><name name-style="western"><surname>Sprinz</surname><given-names>E</given-names></name><name name-style="western"><surname>Sutherland</surname><given-names>RK</given-names></name><name name-style="western"><surname>Tarrant</surname><given-names>R</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>EC</given-names></name><name name-style="western"><surname>T&#246;r&#246;k</surname><given-names>ME</given-names></name><name name-style="western"><surname>Toshner</surname><given-names>M</given-names></name><name name-style="western"><surname>Turner</surname><given-names>DPJ</given-names></name><name name-style="western"><surname>Vekemans</surname><given-names>J</given-names></name><name name-style="western"><surname>Villafana</surname><given-names>TL</given-names></name><name name-style="western"><surname>Watson</surname><given-names>MEE</given-names></name><name name-style="western"><surname>Williams</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Douglas</surname><given-names>AD</given-names></name><name name-style="western"><surname>Hill</surname><given-names>AVS</given-names></name><name name-style="western"><surname>Lambe</surname><given-names>T</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name><name name-style="western"><surname>Pollard</surname><given-names>AJ</given-names></name><collab>Oxford COVID Vaccine Trial Group</collab></person-group><article-title>Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK</article-title><source>Lancet</source><year>2021</year><volume>397</volume><issue>10269</issue><fpage>99</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)32661-1</pub-id><pub-id pub-id-type="pmid">33306989</pub-id><pub-id pub-id-type="pmcid">PMC7723445</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sadoff</surname><given-names>J</given-names></name><name name-style="western"><surname>Gray</surname><given-names>G</given-names></name><name name-style="western"><surname>Vandebosch</surname><given-names>A</given-names></name><name name-style="western"><surname>C&#225;rdenas</surname><given-names>V</given-names></name><name name-style="western"><surname>Shukarev</surname><given-names>G</given-names></name><name name-style="western"><surname>Grinsztejn</surname><given-names>B</given-names></name><name name-style="western"><surname>Goepfert</surname><given-names>PA</given-names></name><name name-style="western"><surname>Truyers</surname><given-names>C</given-names></name><name name-style="western"><surname>Fennema</surname><given-names>H</given-names></name><name name-style="western"><surname>Spiessens</surname><given-names>B</given-names></name><name name-style="western"><surname>Offergeld</surname><given-names>K</given-names></name><name name-style="western"><surname>Scheper</surname><given-names>G</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>KL</given-names></name><name name-style="western"><surname>Robb</surname><given-names>ML</given-names></name><name name-style="western"><surname>Treanor</surname><given-names>J</given-names></name><name name-style="western"><surname>Barouch</surname><given-names>DH</given-names></name><name name-style="western"><surname>Stoddard</surname><given-names>J</given-names></name><name name-style="western"><surname>Ryser</surname><given-names>MF</given-names></name><name name-style="western"><surname>Marovich</surname><given-names>MA</given-names></name><name name-style="western"><surname>Neuzil</surname><given-names>KM</given-names></name><name name-style="western"><surname>Corey</surname><given-names>L</given-names></name><name name-style="western"><surname>Cauwenberghs</surname><given-names>N</given-names></name><name name-style="western"><surname>Tanner</surname><given-names>T</given-names></name><name name-style="western"><surname>Hardt</surname><given-names>K</given-names></name><name name-style="western"><surname>Ruiz-Gui&#241;az&#250;</surname><given-names>J</given-names></name><name name-style="western"><surname>Le Gars</surname><given-names>M</given-names></name><name name-style="western"><surname>Schuitemaker</surname><given-names>H</given-names></name><name name-style="western"><surname>Van Hoof</surname><given-names>J</given-names></name><name name-style="western"><surname>Struyf</surname><given-names>F</given-names></name><name name-style="western"><surname>Douoguih</surname><given-names>M</given-names></name><collab>ENSEMBLE Study Group</collab></person-group><article-title>Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>23</issue><fpage>2187</fpage><lpage>2201</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2101544</pub-id><pub-id pub-id-type="pmid">33882225</pub-id><pub-id pub-id-type="pmcid">PMC8220996</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al Kaabi</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xia</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Al Qahtani</surname><given-names>MM</given-names></name><name name-style="western"><surname>Abdulrazzaq</surname><given-names>N</given-names></name><name name-style="western"><surname>Al Nusair</surname><given-names>M</given-names></name><name name-style="western"><surname>Hassany</surname><given-names>M</given-names></name><name name-style="western"><surname>Jawad</surname><given-names>JS</given-names></name><name name-style="western"><surname>Abdalla</surname><given-names>J</given-names></name><name name-style="western"><surname>Hussein</surname><given-names>SE</given-names></name><name name-style="western"><surname>Al Mazrouei</surname><given-names>SK</given-names></name><name name-style="western"><surname>Al Karam</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Lai</surname><given-names>B</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yang</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ma</surname><given-names>R</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>ZM</given-names></name><name name-style="western"><surname>Khan</surname><given-names>T</given-names></name><name name-style="western"><surname>Saifuddin Fasihuddin</surname><given-names>M</given-names></name><name name-style="western"><surname>You</surname><given-names>W</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mahmoud</surname><given-names>S</given-names></name><name name-style="western"><surname>ElTantawy</surname><given-names>I</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>P</given-names></name><name name-style="western"><surname>Koshy</surname><given-names>A</given-names></name><name name-style="western"><surname>Zaher</surname><given-names>WA</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Duan</surname><given-names>K</given-names></name><name name-style="western"><surname>Pan</surname><given-names>A</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name></person-group><article-title>Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial</article-title><source>JAMA</source><year>2021</year><volume>326</volume><issue>1</issue><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1001/jama.2021.8565</pub-id><pub-id pub-id-type="pmid">34037666</pub-id><pub-id pub-id-type="pmcid">PMC8156175</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, Aileni VK, Kanungo S, Rai S, Reddy P, Verma S, Singh C, Redkar S, Mohapatra S, Pandey A, Ranganadin P, Gumashta R, Multani M, Mohammad S, Bhatt P, Kumari L, Sapkal G, Gupta N, Abraham P, Panda S, Prasad S, Bhargava B, Ella K, Vadrevu KM. Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial. medRxiv 2021: 2021.2006.2030. 21259439</mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Palacios R, Batista AP, Albuquerque CSN, Pati&#241;o EG, Santos JdP, Conde MTRP, Piorelli RdO, J&#250;nior LCP, Raboni SM, Ramos F, Romero GAS, Leal FE, Camargo LFA, Aoki FH, Coelho EB, Oliveira DS, Fontes CJF, Pileggi GCS, Oliveira ALLd, Siqueira AMd, Oliveira DBLd, Botosso VF, Zeng G, Xin Q, Teixeira MM, Nogueira ML, Kallas EG. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study. Preprint from SSRN. 2021. PPR: PPR341815</mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Sinovac. Summary of clinical trial Data of Sinovac&#8217;s COVID-19 vaccine (CoronaVac&#174;). 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.sinovac.com.cn/news/shownews.php?id=1154&amp;lang=en">http://www.sinovac.com.cn/news/shownews.php?id=1154&amp;lang=en</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">World Health Organization. Evidence assessment: Sinovac/CoronaVac COVID-19 vaccine. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://cdn.who.int/media/docs/default-source/immunization/sage/2021/april/5_sage29apr2021_-critical-evidence_sinovac.pdf?sfvrsn=2488098d_5">https://cdn.who.int/media/docs/default-source/immunization/sage/2021/april/5_sage29apr2021_-critical-evidence_sinovac.pdf?sfvrsn=2488098d_5</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanriover</surname><given-names>M D</given-names></name><name name-style="western"><surname>Do&#287;anay</surname><given-names>H L</given-names></name><name name-style="western"><surname>Akova</surname><given-names>M</given-names></name><name name-style="western"><surname>G&#252;ner</surname><given-names>H R</given-names></name><name name-style="western"><surname>Azap</surname><given-names>A</given-names></name><name name-style="western"><surname>Akhan</surname><given-names>S</given-names></name><name name-style="western"><surname>K&#246;se</surname><given-names>&#350;</given-names></name><name name-style="western"><surname>Erdin&#231;</surname><given-names>F &#350;</given-names></name><name name-style="western"><surname>Akal&#305;n</surname><given-names>E H</given-names></name><name name-style="western"><surname>Tabak</surname><given-names>&#214; F</given-names></name><name name-style="western"><surname>Pulluk&#231;u</surname><given-names>H</given-names></name><name name-style="western"><surname>Batum</surname></name><name name-style="western"><surname>&#350;im&#351;ek Yavuz</surname><given-names>S</given-names></name><name name-style="western"><surname>Turhan</surname></name><name name-style="western"><surname>Y&#305;ld&#305;rmak</surname><given-names>M T</given-names></name><name name-style="western"><surname>K&#246;ksal</surname></name><name name-style="western"><surname>Ta&#351;ova</surname><given-names>Y</given-names></name><name name-style="western"><surname>Korten</surname><given-names>V</given-names></name><name name-style="western"><surname>Y&#305;lmaz</surname><given-names>G</given-names></name><name name-style="western"><surname>&#199;elen</surname><given-names>M K</given-names></name><name name-style="western"><surname>Alt&#305;n</surname><given-names>S</given-names></name><name name-style="western"><surname>&#199;elik</surname></name><name name-style="western"><surname>Bay&#305;nd&#305;r</surname><given-names>Y</given-names></name><name name-style="western"><surname>Karao&#287;lan</surname></name><name name-style="western"><surname>Y&#305;lmaz</surname><given-names>A</given-names></name><name name-style="western"><surname>&#214;zkul</surname><given-names>A</given-names></name><name name-style="western"><surname>G&#252;r</surname><given-names>H</given-names></name><name name-style="western"><surname>Unal</surname><given-names>S</given-names></name><collab>CoronaVac Study Group</collab></person-group><article-title>Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey</article-title><source>Lancet</source><year>2021</year><volume>398</volume><issue>10296</issue><fpage>213</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)01429-X</pub-id><pub-id pub-id-type="pmid">34246358</pub-id><pub-id pub-id-type="pmcid">PMC8266301</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heath</surname><given-names>PT</given-names></name><name name-style="western"><surname>Galiza</surname><given-names>EP</given-names></name><name name-style="western"><surname>Baxter</surname><given-names>DN</given-names></name><name name-style="western"><surname>Boffito</surname><given-names>M</given-names></name><name name-style="western"><surname>Browne</surname><given-names>D</given-names></name><name name-style="western"><surname>Burns</surname><given-names>F</given-names></name><name name-style="western"><surname>Chadwick</surname><given-names>DR</given-names></name><name name-style="western"><surname>Clark</surname><given-names>R</given-names></name><name name-style="western"><surname>Cosgrove</surname><given-names>C</given-names></name><name name-style="western"><surname>Galloway</surname><given-names>J</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>AL</given-names></name><name name-style="western"><surname>Heer</surname><given-names>A</given-names></name><name name-style="western"><surname>Higham</surname><given-names>A</given-names></name><name name-style="western"><surname>Iyengar</surname><given-names>S</given-names></name><name name-style="western"><surname>Jamal</surname><given-names>A</given-names></name><name name-style="western"><surname>Jeanes</surname><given-names>C</given-names></name><name name-style="western"><surname>Kalra</surname><given-names>PA</given-names></name><name name-style="western"><surname>Kyriakidou</surname><given-names>C</given-names></name><name name-style="western"><surname>McAuley</surname><given-names>DF</given-names></name><name name-style="western"><surname>Meyrick</surname><given-names>A</given-names></name><name name-style="western"><surname>Minassian</surname><given-names>AM</given-names></name><name name-style="western"><surname>Minton</surname><given-names>J</given-names></name><name name-style="western"><surname>Moore</surname><given-names>P</given-names></name><name name-style="western"><surname>Munsoor</surname><given-names>I</given-names></name><name name-style="western"><surname>Nicholls</surname><given-names>H</given-names></name><name name-style="western"><surname>Osanlou</surname><given-names>O</given-names></name><name name-style="western"><surname>Packham</surname><given-names>J</given-names></name><name name-style="western"><surname>Pretswell</surname><given-names>CH</given-names></name><name name-style="western"><surname>San Francisco Ramos</surname><given-names>A</given-names></name><name name-style="western"><surname>Saralaya</surname><given-names>D</given-names></name><name name-style="western"><surname>Sheridan</surname><given-names>RP</given-names></name><name name-style="western"><surname>Smith</surname><given-names>R</given-names></name><name name-style="western"><surname>Soiza</surname><given-names>RL</given-names></name><name name-style="western"><surname>Swift</surname><given-names>PA</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>EC</given-names></name><name name-style="western"><surname>Turner</surname><given-names>J</given-names></name><name name-style="western"><surname>Viljoen</surname><given-names>ME</given-names></name><name name-style="western"><surname>Albert</surname><given-names>G</given-names></name><name name-style="western"><surname>Cho</surname><given-names>I</given-names></name><name name-style="western"><surname>Dubovsky</surname><given-names>F</given-names></name><name name-style="western"><surname>Glenn</surname><given-names>G</given-names></name><name name-style="western"><surname>Rivers</surname><given-names>J</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>A</given-names></name><name name-style="western"><surname>Smith</surname><given-names>K</given-names></name><name name-style="western"><surname>Toback</surname><given-names>S</given-names></name><collab>2019nCoV-302 Study Group</collab></person-group><article-title>Safety and efficacy of NVX-CoV2373 Covid-19 vaccine</article-title><source>N Engl J Med</source><year>2021</year><volume>385</volume><issue>13</issue><fpage>1172</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2107659</pub-id><pub-id pub-id-type="pmid">34192426</pub-id><pub-id pub-id-type="pmcid">PMC8262625</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Novavax. PREVENT-19 phase 3 trial Data factsheet. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://wdet.org/media/wdet/assets/2021/06/17/Novavax-PREVENT-19-Trial-Data-Factsheet-2021-06-14-v6-EN.pdf">https://wdet.org/media/wdet/assets/2021/06/17/Novavax-PREVENT-19-Trial-Data-Factsheet-2021-06-14-v6-EN.pdf</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossman</surname><given-names>H</given-names></name><name name-style="western"><surname>Shilo</surname><given-names>S</given-names></name><name name-style="western"><surname>Meir</surname><given-names>T</given-names></name><name name-style="western"><surname>Gorfine</surname><given-names>M</given-names></name><name name-style="western"><surname>Shalit</surname><given-names>U</given-names></name><name name-style="western"><surname>Segal</surname><given-names>E</given-names></name></person-group><article-title>COVID-19 dynamics after a national immunization program in Israel</article-title><source>Nat Med</source><year>2021</year><volume>27</volume><issue>6</issue><fpage>1055</fpage><lpage>1061</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01337-2</pub-id><pub-id pub-id-type="pmid">33875890</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dagan</surname><given-names>N</given-names></name><name name-style="western"><surname>Barda</surname><given-names>N</given-names></name><name name-style="western"><surname>Kepten</surname><given-names>E</given-names></name><name name-style="western"><surname>Miron</surname><given-names>O</given-names></name><name name-style="western"><surname>Perchik</surname><given-names>S</given-names></name><name name-style="western"><surname>Katz</surname><given-names>MA</given-names></name><name name-style="western"><surname>Hern&#225;n</surname><given-names>MA</given-names></name><name name-style="western"><surname>Lipsitch</surname><given-names>M</given-names></name><name name-style="western"><surname>Reis</surname><given-names>B</given-names></name><name name-style="western"><surname>Balicer</surname><given-names>RD</given-names></name></person-group><article-title>BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>15</issue><fpage>1412</fpage><lpage>1423</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2101765</pub-id><pub-id pub-id-type="pmid">33626250</pub-id><pub-id pub-id-type="pmcid">PMC7944975</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jara</surname><given-names>A</given-names></name><name name-style="western"><surname>Undurraga</surname><given-names>EA</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>C</given-names></name><name name-style="western"><surname>Paredes</surname><given-names>F</given-names></name><name name-style="western"><surname>Fontecilla</surname><given-names>T</given-names></name><name name-style="western"><surname>Jara</surname><given-names>G</given-names></name><name name-style="western"><surname>Pizarro</surname><given-names>A</given-names></name><name name-style="western"><surname>Acevedo</surname><given-names>J</given-names></name><name name-style="western"><surname>Leo</surname><given-names>K</given-names></name><name name-style="western"><surname>Leon</surname><given-names>F</given-names></name><name name-style="western"><surname>Sans</surname><given-names>C</given-names></name><name name-style="western"><surname>Leighton</surname><given-names>P</given-names></name><name name-style="western"><surname>Su&#225;rez</surname><given-names>P</given-names></name><name name-style="western"><surname>Garc&#237;a-Escorza</surname><given-names>H</given-names></name><name name-style="western"><surname>Araos</surname><given-names>R</given-names></name></person-group><article-title>Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile</article-title><source>N Engl J Med</source><year>2021</year><volume>385</volume><issue>10</issue><fpage>875</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2107715</pub-id><pub-id pub-id-type="pmid">34233097</pub-id><pub-id pub-id-type="pmcid">PMC8279092</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Corchado-Garcia J, Puyraimond-Zemmour D, Hughes T, Cristea-Platon T, Lenehan P, Pawlowski C, Bade S, O&#8217;Horo JC, Gores GJ, Williams AW, Badley AD, Halamka J, Virk A, Swift MD, Wagner T, Soundararajan V. Real-world effectiveness of Ad26.COV2.S adenoviral vector vaccine for COVID-19. medRxiv 2021: 2021.04.27.21256193<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2021.32540</pub-id><pub-id pub-id-type="pmcid">PMC8564583</pub-id><pub-id pub-id-type="pmid">34726743</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>MG</given-names></name><name name-style="western"><surname>Burgess</surname><given-names>JL</given-names></name><name name-style="western"><surname>Naleway</surname><given-names>AL</given-names></name><name name-style="western"><surname>Tyner</surname><given-names>HL</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>SK</given-names></name><name name-style="western"><surname>Meece</surname><given-names>J</given-names></name><name name-style="western"><surname>Olsho</surname><given-names>LEW</given-names></name><name name-style="western"><surname>Caban-Martinez</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Fowlkes</surname><given-names>A</given-names></name><name name-style="western"><surname>Lutrick</surname><given-names>K</given-names></name><name name-style="western"><surname>Kuntz</surname><given-names>JL</given-names></name><name name-style="western"><surname>Dunnigan</surname><given-names>K</given-names></name><name name-style="western"><surname>Odean</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Hegmann</surname><given-names>KT</given-names></name><name name-style="western"><surname>Stefanski</surname><given-names>E</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Schaefer-Solle</surname><given-names>N</given-names></name><name name-style="western"><surname>Grant</surname><given-names>L</given-names></name><name name-style="western"><surname>Ellingson</surname><given-names>K</given-names></name><name name-style="western"><surname>Groom</surname><given-names>HC</given-names></name><name name-style="western"><surname>Zunie</surname><given-names>T</given-names></name><name name-style="western"><surname>Thiese</surname><given-names>MS</given-names></name><name name-style="western"><surname>Ivacic</surname><given-names>L</given-names></name><name name-style="western"><surname>Wesley</surname><given-names>MG</given-names></name><name name-style="western"><surname>Lamberte</surname><given-names>JM</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Smith</surname><given-names>ME</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>AL</given-names></name><name name-style="western"><surname>Groover</surname><given-names>KD</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>YM</given-names></name><name name-style="western"><surname>Gerald</surname><given-names>J</given-names></name><name name-style="western"><surname>Brown</surname><given-names>RT</given-names></name><name name-style="western"><surname>Herring</surname><given-names>MK</given-names></name><name name-style="western"><surname>Joseph</surname><given-names>G</given-names></name><name name-style="western"><surname>Beitel</surname><given-names>S</given-names></name><name name-style="western"><surname>Morrill</surname><given-names>TC</given-names></name><name name-style="western"><surname>Mak</surname><given-names>J</given-names></name><name name-style="western"><surname>Rivers</surname><given-names>P</given-names></name><name name-style="western"><surname>Harris</surname><given-names>KM</given-names></name><name name-style="western"><surname>Hunt</surname><given-names>DR</given-names></name><name name-style="western"><surname>Arvay</surname><given-names>ML</given-names></name><name name-style="western"><surname>Kutty</surname><given-names>P</given-names></name><name name-style="western"><surname>Fry</surname><given-names>AM</given-names></name><name name-style="western"><surname>Gaglani</surname><given-names>M</given-names></name></person-group><article-title>Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers&#8212;eight U.S. locations, December 2020-March 2021</article-title><source>MMWRMorb Mortal Wkly Rep</source><year>2021</year><volume>70</volume><issue>13</issue><fpage>495</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm7013e3</pub-id><pub-id pub-id-type="pmcid">PMC8022879</pub-id><pub-id pub-id-type="pmid">33793460</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doherty</surname><given-names>M</given-names></name><name name-style="western"><surname>Buchy</surname><given-names>P</given-names></name><name name-style="western"><surname>Standaert</surname><given-names>B</given-names></name><name name-style="western"><surname>Giaquinto</surname><given-names>C</given-names></name><name name-style="western"><surname>Prado-Cohrs</surname><given-names>D</given-names></name></person-group><article-title>Vaccine impact: benefits for human health</article-title><source>Vaccine</source><year>2016</year><volume>34</volume><issue>52</issue><fpage>6707</fpage><lpage>6714</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2016.10.025</pub-id><pub-id pub-id-type="pmid">27773475</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>MG</given-names></name><name name-style="western"><surname>Burgess</surname><given-names>JL</given-names></name><name name-style="western"><surname>Naleway</surname><given-names>AL</given-names></name><name name-style="western"><surname>Tyner</surname><given-names>H</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>SK</given-names></name><name name-style="western"><surname>Meece</surname><given-names>J</given-names></name><name name-style="western"><surname>Olsho</surname><given-names>LEW</given-names></name><name name-style="western"><surname>Caban-Martinez</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Fowlkes</surname><given-names>AL</given-names></name><name name-style="western"><surname>Lutrick</surname><given-names>K</given-names></name><name name-style="western"><surname>Groom</surname><given-names>HC</given-names></name><name name-style="western"><surname>Dunnigan</surname><given-names>K</given-names></name><name name-style="western"><surname>Odean</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Hegmann</surname><given-names>K</given-names></name><name name-style="western"><surname>Stefanski</surname><given-names>E</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Schaefer-Solle</surname><given-names>N</given-names></name><name name-style="western"><surname>Grant</surname><given-names>L</given-names></name><name name-style="western"><surname>Ellingson</surname><given-names>K</given-names></name><name name-style="western"><surname>Kuntz</surname><given-names>JL</given-names></name><name name-style="western"><surname>Zunie</surname><given-names>T</given-names></name><name name-style="western"><surname>Thiese</surname><given-names>MS</given-names></name><name name-style="western"><surname>Ivacic</surname><given-names>L</given-names></name><name name-style="western"><surname>Wesley</surname><given-names>MG</given-names></name><name name-style="western"><surname>Mayo Lamberte</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Smith</surname><given-names>ME</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>AL</given-names></name><name name-style="western"><surname>Groover</surname><given-names>KD</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>YM</given-names></name><name name-style="western"><surname>Gerald</surname><given-names>J</given-names></name><name name-style="western"><surname>Brown</surname><given-names>RT</given-names></name><name name-style="western"><surname>Herring</surname><given-names>MK</given-names></name><name name-style="western"><surname>Joseph</surname><given-names>G</given-names></name><name name-style="western"><surname>Beitel</surname><given-names>S</given-names></name><name name-style="western"><surname>Morrill</surname><given-names>TC</given-names></name><name name-style="western"><surname>Mak</surname><given-names>J</given-names></name><name name-style="western"><surname>Rivers</surname><given-names>P</given-names></name><name name-style="western"><surname>Poe</surname><given-names>BP</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Kelleher</surname><given-names>A</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dickerson</surname><given-names>M</given-names></name><name name-style="western"><surname>Hanson</surname><given-names>E</given-names></name><name name-style="western"><surname>Guenther</surname><given-names>K</given-names></name><name name-style="western"><surname>Tong</surname><given-names>S</given-names></name><name name-style="western"><surname>Bateman</surname><given-names>A</given-names></name><name name-style="western"><surname>Reisdorf</surname><given-names>E</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>J</given-names></name><name name-style="western"><surname>Azziz-Baumgartner</surname><given-names>E</given-names></name><name name-style="western"><surname>Hunt</surname><given-names>DR</given-names></name><name name-style="western"><surname>Arvay</surname><given-names>ML</given-names></name><name name-style="western"><surname>Kutty</surname><given-names>P</given-names></name><name name-style="western"><surname>Fry</surname><given-names>AM</given-names></name><name name-style="western"><surname>Gaglani</surname><given-names>M</given-names></name></person-group><article-title>Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines</article-title><source>N Engl J Med</source><year>2021</year><volume>385</volume><issue>4</issue><fpage>320</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2107058</pub-id><pub-id pub-id-type="pmid">34192428</pub-id><pub-id pub-id-type="pmcid">PMC8262622</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Bernal JL, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G, Myers R, Campbell C, Amirthalingam G, Edmunds M, Zambon M, Brown K, Hopkins S, Chand M, Ramsay M. Effectiveness of COVID-19 vaccines against the B.1.617.2 variant. medRxiv 2021: 2021.2005.2022.21257658</mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="other">Public Health England. Vaccines highly effective against hospitalisation from Delta variant. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.gov.uk/government/news/vaccines-highly-effective-against-hospitalisation-from-Delta-variant">https://www.gov.uk/government/news/vaccines-highly-effective-against-hospitalisation-from-Delta-variant</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vasileiou</surname><given-names>E</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>CR</given-names></name><name name-style="western"><surname>Shi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kerr</surname><given-names>S</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>U</given-names></name><name name-style="western"><surname>Akbari</surname><given-names>A</given-names></name><name name-style="western"><surname>Bedston</surname><given-names>S</given-names></name><name name-style="western"><surname>Beggs</surname><given-names>J</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>D</given-names></name><name name-style="western"><surname>Chuter</surname><given-names>A</given-names></name><name name-style="western"><surname>de Lusignan</surname><given-names>S</given-names></name><name name-style="western"><surname>Docherty</surname><given-names>AB</given-names></name><name name-style="western"><surname>Ford</surname><given-names>D</given-names></name><name name-style="western"><surname>Hobbs</surname><given-names>FR</given-names></name><name name-style="western"><surname>Joy</surname><given-names>M</given-names></name><name name-style="western"><surname>Katikireddi</surname><given-names>SV</given-names></name><name name-style="western"><surname>Marple</surname><given-names>J</given-names></name><name name-style="western"><surname>McCowan</surname><given-names>C</given-names></name><name name-style="western"><surname>McGagh</surname><given-names>D</given-names></name><name name-style="western"><surname>McMenamin</surname><given-names>J</given-names></name><name name-style="western"><surname>Moore</surname><given-names>E</given-names></name><name name-style="western"><surname>Murray</surname><given-names>JL</given-names></name><name name-style="western"><surname>Pan</surname><given-names>J</given-names></name><name name-style="western"><surname>Ritchie</surname><given-names>L</given-names></name><name name-style="western"><surname>Shah</surname><given-names>SA</given-names></name><name name-style="western"><surname>Stock</surname><given-names>S</given-names></name><name name-style="western"><surname>Torabi</surname><given-names>F</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>RS</given-names></name><name name-style="western"><surname>Wood</surname><given-names>R</given-names></name><name name-style="western"><surname>Woolhouse</surname><given-names>M</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>C</given-names></name><name name-style="western"><surname>Sheikh</surname><given-names>A</given-names></name></person-group><article-title>Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study</article-title><source>Lancet</source><year>2021</year><volume>397</volume><issue>10285</issue><fpage>1646</fpage><lpage>1657</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00677-2</pub-id><pub-id pub-id-type="pmid">33901420</pub-id><pub-id pub-id-type="pmcid">PMC8064669</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation</collab><name name-style="western"><surname>Krause</surname><given-names>PR</given-names></name><name name-style="western"><surname>Fleming</surname><given-names>TR</given-names></name><name name-style="western"><surname>Longini</surname><given-names>IM</given-names></name><name name-style="western"><surname>Peto</surname><given-names>R</given-names></name><name name-style="western"><surname>Beral</surname><given-names>V</given-names></name><name name-style="western"><surname>Bhargava</surname><given-names>B</given-names></name><name name-style="western"><surname>Cravioto</surname><given-names>A</given-names></name><name name-style="western"><surname>Cramer</surname><given-names>JP</given-names></name><name name-style="western"><surname>Ellenberg</surname><given-names>SS</given-names></name><name name-style="western"><surname>Figueroa</surname><given-names>JP</given-names></name><name name-style="western"><surname>Halloran</surname><given-names>E</given-names></name><name name-style="western"><surname>Henao-Restrepo</surname><given-names>AM</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Levine</surname><given-names>MM</given-names></name><name name-style="western"><surname>Nason</surname><given-names>M</given-names></name><name name-style="western"><surname>Nohynek</surname><given-names>HM</given-names></name><name name-style="western"><surname>Plotkin</surname><given-names>S</given-names></name><name name-style="western"><surname>Rees</surname><given-names>H</given-names></name><name name-style="western"><surname>Singh</surname><given-names>JA</given-names></name><name name-style="western"><surname>Swaminathan</surname><given-names>S</given-names></name></person-group><article-title>Placebo-controlled trials of Covid-19 vaccines&#8212;why we still need them</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>2</issue><fpage>e2</fpage><pub-id pub-id-type="doi">10.1056/NEJMp2033538</pub-id><pub-id pub-id-type="pmid">33264543</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wendler</surname><given-names>D</given-names></name><name name-style="western"><surname>Ochoa</surname><given-names>J</given-names></name><name name-style="western"><surname>Millum</surname><given-names>J</given-names></name><name name-style="western"><surname>Grady</surname><given-names>C</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>HA</given-names></name></person-group><article-title>COVID-19 vaccine trial ethics once we have efficacious vaccines</article-title><source>Science</source><year>2020</year><volume>370</volume><issue>6522</issue><fpage>1277</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1126/science.abf5084</pub-id><pub-id pub-id-type="pmid">33273060</pub-id><pub-id pub-id-type="pmcid">PMC10107693</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Follmann</surname><given-names>D</given-names></name><name name-style="western"><surname>Fintzi</surname><given-names>J</given-names></name><name name-style="western"><surname>Fay</surname><given-names>MP</given-names></name><name name-style="western"><surname>Janes</surname><given-names>HE</given-names></name><name name-style="western"><surname>Baden</surname><given-names>LR</given-names></name><name name-style="western"><surname>El Sahly</surname><given-names>HM</given-names></name><name name-style="western"><surname>Fleming</surname><given-names>TR</given-names></name><name name-style="western"><surname>Mehrotra</surname><given-names>DV</given-names></name><name name-style="western"><surname>Carpp</surname><given-names>LN</given-names></name><name name-style="western"><surname>Juraska</surname><given-names>M</given-names></name><name name-style="western"><surname>Benkeser</surname><given-names>D</given-names></name><name name-style="western"><surname>Donnell</surname><given-names>D</given-names></name><name name-style="western"><surname>Fong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>S</given-names></name><name name-style="western"><surname>Hirsch</surname><given-names>I</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hyrien</surname><given-names>O</given-names></name><name name-style="western"><surname>Luedtke</surname><given-names>A</given-names></name><name name-style="western"><surname>Carone</surname><given-names>M</given-names></name><name name-style="western"><surname>Nason</surname><given-names>M</given-names></name><name name-style="western"><surname>Vandebosch</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Cho</surname><given-names>I</given-names></name><name name-style="western"><surname>Gabriel</surname><given-names>E</given-names></name><name name-style="western"><surname>Kublin</surname><given-names>JG</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>MS</given-names></name><name name-style="western"><surname>Corey</surname><given-names>L</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>PB</given-names></name><name name-style="western"><surname>Neuzil</surname><given-names>KM</given-names></name></person-group><article-title>A deferred-vaccination design to assess durability of COVID-19 vaccine effect after the placebo group is vaccinated</article-title><source>Ann Intern Med</source><year>2021</year><volume>174</volume><issue>8</issue><fpage>1118</fpage><lpage>1125</lpage><pub-id pub-id-type="doi">10.7326/M20-8149</pub-id><pub-id pub-id-type="pmid">33844575</pub-id><pub-id pub-id-type="pmcid">PMC8099035</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>P</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Pan</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>F</given-names></name></person-group><article-title>Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need</article-title><source>Signal Transduct Target Ther</source><year>2021</year><volume>6</volume><issue>1</issue><fpage>48</fpage><pub-id pub-id-type="doi">10.1038/s41392-021-00481-y</pub-id><pub-id pub-id-type="pmid">33531462</pub-id><pub-id pub-id-type="pmcid">PMC7851657</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Rouphael</surname><given-names>NG</given-names></name><name name-style="western"><surname>Widge</surname><given-names>AT</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>LA</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>PC</given-names></name><name name-style="western"><surname>Makhene</surname><given-names>M</given-names></name><name name-style="western"><surname>Chappell</surname><given-names>JD</given-names></name><name name-style="western"><surname>Denison</surname><given-names>MR</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Pruijssers</surname><given-names>AJ</given-names></name><name name-style="western"><surname>McDermott</surname><given-names>AB</given-names></name><name name-style="western"><surname>Flach</surname><given-names>B</given-names></name><name name-style="western"><surname>Lin</surname><given-names>BC</given-names></name><name name-style="western"><surname>Doria-Rose</surname><given-names>NA</given-names></name><name name-style="western"><surname>O&#8217;Dell</surname><given-names>S</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>SD</given-names></name><name name-style="western"><surname>Corbett</surname><given-names>KS</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>PA</given-names><suffix>2nd</suffix></name><name name-style="western"><surname>Padilla</surname><given-names>M</given-names></name><name name-style="western"><surname>Neuzil</surname><given-names>KM</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>H</given-names></name><name name-style="western"><surname>Leav</surname><given-names>B</given-names></name><name name-style="western"><surname>Makowski</surname><given-names>M</given-names></name><name name-style="western"><surname>Albert</surname><given-names>J</given-names></name><name name-style="western"><surname>Cross</surname><given-names>K</given-names></name><name name-style="western"><surname>Edara</surname><given-names>VV</given-names></name><name name-style="western"><surname>Floyd</surname><given-names>K</given-names></name><name name-style="western"><surname>Suthar</surname><given-names>MS</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>DR</given-names></name><name name-style="western"><surname>Baric</surname><given-names>R</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>W</given-names></name><name name-style="western"><surname>Luke</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Phadke</surname><given-names>VK</given-names></name><name name-style="western"><surname>Rostad</surname><given-names>CA</given-names></name><name name-style="western"><surname>Ledgerwood</surname><given-names>JE</given-names></name><name name-style="western"><surname>Graham</surname><given-names>BS</given-names></name><name name-style="western"><surname>Beigel</surname><given-names>JH</given-names></name><collab>mRNA-1273 Study Group</collab></person-group><article-title>Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><issue>25</issue><fpage>2427</fpage><lpage>2438</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2028436</pub-id><pub-id pub-id-type="pmid">32991794</pub-id><pub-id pub-id-type="pmcid">PMC7556339</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ella</surname><given-names>R</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>S</given-names></name><name name-style="western"><surname>Jogdand</surname><given-names>H</given-names></name><name name-style="western"><surname>Sarangi</surname><given-names>V</given-names></name><name name-style="western"><surname>Ganneru</surname><given-names>B</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>S</given-names></name><name name-style="western"><surname>Das</surname><given-names>D</given-names></name><name name-style="western"><surname>Raju</surname><given-names>D</given-names></name><name name-style="western"><surname>Praturi</surname><given-names>U</given-names></name><name name-style="western"><surname>Sapkal</surname><given-names>G</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>P</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>P</given-names></name><name name-style="western"><surname>Verma</surname><given-names>S</given-names></name><name name-style="western"><surname>Singh</surname><given-names>C</given-names></name><name name-style="western"><surname>Redkar</surname><given-names>SV</given-names></name><name name-style="western"><surname>Gillurkar</surname><given-names>CS</given-names></name><name name-style="western"><surname>Kushwaha</surname><given-names>JS</given-names></name><name name-style="western"><surname>Mohapatra</surname><given-names>S</given-names></name><name name-style="western"><surname>Bhate</surname><given-names>A</given-names></name><name name-style="western"><surname>Rai</surname><given-names>S</given-names></name><name name-style="western"><surname>Panda</surname><given-names>S</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>P</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>N</given-names></name><name name-style="western"><surname>Ella</surname><given-names>K</given-names></name><name name-style="western"><surname>Bhargava</surname><given-names>B</given-names></name><name name-style="western"><surname>Vadrevu</surname><given-names>KM</given-names></name></person-group><article-title>Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial</article-title><source>Lancet Infect Dis</source><year>2021</year><volume>21</volume><issue>7</issue><fpage>950</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(21)00070-0</pub-id><pub-id pub-id-type="pmid">33705727</pub-id><pub-id pub-id-type="pmcid">PMC8221739</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Folegatti</surname><given-names>PM</given-names></name><name name-style="western"><surname>Ewer</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Aley</surname><given-names>PK</given-names></name><name name-style="western"><surname>Angus</surname><given-names>B</given-names></name><name name-style="western"><surname>Becker</surname><given-names>S</given-names></name><name name-style="western"><surname>Belij-Rammerstorfer</surname><given-names>S</given-names></name><name name-style="western"><surname>Bellamy</surname><given-names>D</given-names></name><name name-style="western"><surname>Bibi</surname><given-names>S</given-names></name><name name-style="western"><surname>Bittaye</surname><given-names>M</given-names></name><name name-style="western"><surname>Clutterbuck</surname><given-names>EA</given-names></name><name name-style="western"><surname>Dold</surname><given-names>C</given-names></name><name name-style="western"><surname>Faust</surname><given-names>SN</given-names></name><name name-style="western"><surname>Finn</surname><given-names>A</given-names></name><name name-style="western"><surname>Flaxman</surname><given-names>AL</given-names></name><name name-style="western"><surname>Hallis</surname><given-names>B</given-names></name><name name-style="western"><surname>Heath</surname><given-names>P</given-names></name><name name-style="western"><surname>Jenkin</surname><given-names>D</given-names></name><name name-style="western"><surname>Lazarus</surname><given-names>R</given-names></name><name name-style="western"><surname>Makinson</surname><given-names>R</given-names></name><name name-style="western"><surname>Minassian</surname><given-names>AM</given-names></name><name name-style="western"><surname>Pollock</surname><given-names>KM</given-names></name><name name-style="western"><surname>Ramasamy</surname><given-names>M</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>H</given-names></name><name name-style="western"><surname>Snape</surname><given-names>M</given-names></name><name name-style="western"><surname>Tarrant</surname><given-names>R</given-names></name><name name-style="western"><surname>Voysey</surname><given-names>M</given-names></name><name name-style="western"><surname>Green</surname><given-names>C</given-names></name><name name-style="western"><surname>Douglas</surname><given-names>AD</given-names></name><name name-style="western"><surname>Hill</surname><given-names>AVS</given-names></name><name name-style="western"><surname>Lambe</surname><given-names>T</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name><name name-style="western"><surname>Pollard</surname><given-names>AJ</given-names></name><collab>Oxford COVID Vaccine Trial Group</collab></person-group><article-title>Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial</article-title><source>Lancet</source><year>2020</year><volume>396</volume><issue>10249</issue><fpage>467</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31604-4</pub-id><pub-id pub-id-type="pmid">32702298</pub-id><pub-id pub-id-type="pmcid">PMC7445431</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Formica N, Mallory R, Albert G, Robinson M, Plested JS, Cho I, Robertson A, Dubovsky F, Glenn GM. Evaluation of a SARS-CoV-2 vaccine NVX-CoV2373 in younger and older adults. medRxiv 2021: 2021.2002.2026.21252482<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pmed.1003769</pub-id><pub-id pub-id-type="pmcid">PMC8486115</pub-id><pub-id pub-id-type="pmid">34597298</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keech</surname><given-names>C</given-names></name><name name-style="western"><surname>Albert</surname><given-names>G</given-names></name><name name-style="western"><surname>Cho</surname><given-names>I</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>A</given-names></name><name name-style="western"><surname>Reed</surname><given-names>P</given-names></name><name name-style="western"><surname>Neal</surname><given-names>S</given-names></name><name name-style="western"><surname>Plested</surname><given-names>JS</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Cloney-Clark</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Smith</surname><given-names>G</given-names></name><name name-style="western"><surname>Patel</surname><given-names>N</given-names></name><name name-style="western"><surname>Frieman</surname><given-names>MB</given-names></name><name name-style="western"><surname>Haupt</surname><given-names>RE</given-names></name><name name-style="western"><surname>Logue</surname><given-names>J</given-names></name><name name-style="western"><surname>McGrath</surname><given-names>M</given-names></name><name name-style="western"><surname>Weston</surname><given-names>S</given-names></name><name name-style="western"><surname>Piedra</surname><given-names>PA</given-names></name><name name-style="western"><surname>Desai</surname><given-names>C</given-names></name><name name-style="western"><surname>Callahan</surname><given-names>K</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>M</given-names></name><name name-style="western"><surname>Price-Abbott</surname><given-names>P</given-names></name><name name-style="western"><surname>Formica</surname><given-names>N</given-names></name><name name-style="western"><surname>Shinde</surname><given-names>V</given-names></name><name name-style="western"><surname>Fries</surname><given-names>L</given-names></name><name name-style="western"><surname>Lickliter</surname><given-names>JD</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>P</given-names></name><name name-style="western"><surname>Wilkinson</surname><given-names>B</given-names></name><name name-style="western"><surname>Glenn</surname><given-names>GM</given-names></name></person-group><article-title>Phase 1&#8211;2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><issue>24</issue><fpage>2320</fpage><lpage>2332</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2026920</pub-id><pub-id pub-id-type="pmid">32877576</pub-id><pub-id pub-id-type="pmcid">PMC7494251</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Logunov</surname><given-names>DY</given-names></name><name name-style="western"><surname>Dolzhikova</surname><given-names>IV</given-names></name><name name-style="western"><surname>Zubkova</surname><given-names>OV</given-names></name><name name-style="western"><surname>Tukhvatullin</surname><given-names>AI</given-names></name><name name-style="western"><surname>Shcheblyakov</surname><given-names>DV</given-names></name><name name-style="western"><surname>Dzharullaeva</surname><given-names>AS</given-names></name><name name-style="western"><surname>Grousova</surname><given-names>DM</given-names></name><name name-style="western"><surname>Erokhova</surname><given-names>AS</given-names></name><name name-style="western"><surname>Kovyrshina</surname><given-names>AV</given-names></name><name name-style="western"><surname>Botikov</surname><given-names>AG</given-names></name><name name-style="western"><surname>Izhaeva</surname><given-names>FM</given-names></name><name name-style="western"><surname>Popova</surname><given-names>O</given-names></name><name name-style="western"><surname>Ozharovskaya</surname><given-names>TA</given-names></name><name name-style="western"><surname>Esmagambetov</surname><given-names>IB</given-names></name><name name-style="western"><surname>Favorskaya</surname><given-names>IA</given-names></name><name name-style="western"><surname>Zrelkin</surname><given-names>DI</given-names></name><name name-style="western"><surname>Voronina</surname><given-names>DV</given-names></name><name name-style="western"><surname>Shcherbinin</surname><given-names>DN</given-names></name><name name-style="western"><surname>Semikhin</surname><given-names>AS</given-names></name><name name-style="western"><surname>Simakova</surname><given-names>YV</given-names></name><name name-style="western"><surname>Tokarskaya</surname><given-names>EA</given-names></name><name name-style="western"><surname>Lubenets</surname><given-names>NL</given-names></name><name name-style="western"><surname>Egorova</surname><given-names>DA</given-names></name><name name-style="western"><surname>Shmarov</surname><given-names>MM</given-names></name><name name-style="western"><surname>Nikitenko</surname><given-names>NA</given-names></name><name name-style="western"><surname>Morozova</surname><given-names>LF</given-names></name><name name-style="western"><surname>Smolyarchuk</surname><given-names>EA</given-names></name><name name-style="western"><surname>Kryukov</surname><given-names>EV</given-names></name><name name-style="western"><surname>Babira</surname><given-names>VF</given-names></name><name name-style="western"><surname>Borisevich</surname><given-names>SV</given-names></name><name name-style="western"><surname>Naroditsky</surname><given-names>BS</given-names></name><name name-style="western"><surname>Gintsburg</surname><given-names>AL</given-names></name></person-group><article-title>Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia</article-title><source>Lancet</source><year>2020</year><volume>396</volume><issue>10255</issue><fpage>887</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31866-3</pub-id><pub-id pub-id-type="pmid">32896291</pub-id><pub-id pub-id-type="pmcid">PMC7471804</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramasamy</surname><given-names>MN</given-names></name><name name-style="western"><surname>Minassian</surname><given-names>AM</given-names></name><name name-style="western"><surname>Ewer</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Flaxman</surname><given-names>AL</given-names></name><name name-style="western"><surname>Folegatti</surname><given-names>PM</given-names></name><name name-style="western"><surname>Owens</surname><given-names>DR</given-names></name><name name-style="western"><surname>Voysey</surname><given-names>M</given-names></name><name name-style="western"><surname>Aley</surname><given-names>PK</given-names></name><name name-style="western"><surname>Angus</surname><given-names>B</given-names></name><name name-style="western"><surname>Babbage</surname><given-names>G</given-names></name><name name-style="western"><surname>Belij-Rammerstorfer</surname><given-names>S</given-names></name><name name-style="western"><surname>Berry</surname><given-names>L</given-names></name><name name-style="western"><surname>Bibi</surname><given-names>S</given-names></name><name name-style="western"><surname>Bittaye</surname><given-names>M</given-names></name><name name-style="western"><surname>Cathie</surname><given-names>K</given-names></name><name name-style="western"><surname>Chappell</surname><given-names>H</given-names></name><name name-style="western"><surname>Charlton</surname><given-names>S</given-names></name><name name-style="western"><surname>Cicconi</surname><given-names>P</given-names></name><name name-style="western"><surname>Clutterbuck</surname><given-names>EA</given-names></name><name name-style="western"><surname>Colin-Jones</surname><given-names>R</given-names></name><name name-style="western"><surname>Dold</surname><given-names>C</given-names></name><name name-style="western"><surname>Emary</surname><given-names>KRW</given-names></name><name name-style="western"><surname>Fedosyuk</surname><given-names>S</given-names></name><name name-style="western"><surname>Fuskova</surname><given-names>M</given-names></name><name name-style="western"><surname>Gbesemete</surname><given-names>D</given-names></name><name name-style="western"><surname>Green</surname><given-names>C</given-names></name><name name-style="western"><surname>Hallis</surname><given-names>B</given-names></name><name name-style="western"><surname>Hou</surname><given-names>MM</given-names></name><name name-style="western"><surname>Jenkin</surname><given-names>D</given-names></name><name name-style="western"><surname>Joe</surname><given-names>CCD</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Kerridge</surname><given-names>S</given-names></name><name name-style="western"><surname>Lawrie</surname><given-names>AM</given-names></name><name name-style="western"><surname>Lelliott</surname><given-names>A</given-names></name><name name-style="western"><surname>Lwin</surname><given-names>MN</given-names></name><name name-style="western"><surname>Makinson</surname><given-names>R</given-names></name><name name-style="western"><surname>Marchevsky</surname><given-names>NG</given-names></name><name name-style="western"><surname>Mujadidi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Munro</surname><given-names>APS</given-names></name><name name-style="western"><surname>Pacurar</surname><given-names>M</given-names></name><name name-style="western"><surname>Plested</surname><given-names>E</given-names></name><name name-style="western"><surname>Rand</surname><given-names>J</given-names></name><name name-style="western"><surname>Rawlinson</surname><given-names>T</given-names></name><name name-style="western"><surname>Rhead</surname><given-names>S</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>H</given-names></name><name name-style="western"><surname>Ritchie</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Ross-Russell</surname><given-names>AL</given-names></name><name name-style="western"><surname>Saich</surname><given-names>S</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N</given-names></name><name name-style="western"><surname>Smith</surname><given-names>CC</given-names></name><name name-style="western"><surname>Snape</surname><given-names>MD</given-names></name><name name-style="western"><surname>Song</surname><given-names>R</given-names></name><name name-style="western"><surname>Tarrant</surname><given-names>R</given-names></name><name name-style="western"><surname>Themistocleous</surname><given-names>Y</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>KM</given-names></name><name name-style="western"><surname>Villafana</surname><given-names>TL</given-names></name><name name-style="western"><surname>Warren</surname><given-names>SC</given-names></name><name name-style="western"><surname>Watson</surname><given-names>MEE</given-names></name><name name-style="western"><surname>Douglas</surname><given-names>AD</given-names></name><name name-style="western"><surname>Hill</surname><given-names>AVS</given-names></name><name name-style="western"><surname>Lambe</surname><given-names>T</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name><name name-style="western"><surname>Faust</surname><given-names>SN</given-names></name><name name-style="western"><surname>Pollard</surname><given-names>AJ</given-names></name><collab>Oxford COVID Vaccine Trial Group</collab></person-group><article-title>Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial</article-title><source>Lancet</source><year>2021</year><volume>396</volume><issue>10267</issue><fpage>1979</fpage><lpage>1993</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)32466-1</pub-id><pub-id pub-id-type="pmid">33220855</pub-id><pub-id pub-id-type="pmcid">PMC7674972</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sadoff</surname><given-names>J</given-names></name><name name-style="western"><surname>Le Gars</surname><given-names>M</given-names></name><name name-style="western"><surname>Shukarev</surname><given-names>G</given-names></name><name name-style="western"><surname>Heerwegh</surname><given-names>D</given-names></name><name name-style="western"><surname>Truyers</surname><given-names>C</given-names></name><name name-style="western"><surname>de Groot</surname><given-names>AM</given-names></name><name name-style="western"><surname>Stoop</surname><given-names>J</given-names></name><name name-style="western"><surname>Tete</surname><given-names>S</given-names></name><name name-style="western"><surname>Van Damme</surname><given-names>W</given-names></name><name name-style="western"><surname>Leroux-Roels</surname><given-names>I</given-names></name><name name-style="western"><surname>Berghmans</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Kimmel</surname><given-names>M</given-names></name><name name-style="western"><surname>Van Damme</surname><given-names>P</given-names></name><name name-style="western"><surname>de Hoon</surname><given-names>J</given-names></name><name name-style="western"><surname>Smith</surname><given-names>W</given-names></name><name name-style="western"><surname>Stephenson</surname><given-names>KE</given-names></name><name name-style="western"><surname>De Rosa</surname><given-names>SC</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>KW</given-names></name><name name-style="western"><surname>McElrath</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Cormier</surname><given-names>E</given-names></name><name name-style="western"><surname>Scheper</surname><given-names>G</given-names></name><name name-style="western"><surname>Barouch</surname><given-names>DH</given-names></name><name name-style="western"><surname>Hendriks</surname><given-names>J</given-names></name><name name-style="western"><surname>Struyf</surname><given-names>F</given-names></name><name name-style="western"><surname>Douoguih</surname><given-names>M</given-names></name><name name-style="western"><surname>Van Hoof</surname><given-names>J</given-names></name><name name-style="western"><surname>Schuitemaker</surname><given-names>H</given-names></name></person-group><article-title>Interim results of a phase 1&#8211;2a trial of Ad26.COV2.S Covid-19 vaccine</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>19</issue><fpage>1824</fpage><lpage>1835</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2034201</pub-id><pub-id pub-id-type="pmid">33440088</pub-id><pub-id pub-id-type="pmcid">PMC7821985</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walsh</surname><given-names>EE</given-names></name><name name-style="western"><surname>Frenck</surname><given-names>RW</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Falsey</surname><given-names>AR</given-names></name><name name-style="western"><surname>Kitchin</surname><given-names>N</given-names></name><name name-style="western"><surname>Absalon</surname><given-names>J</given-names></name><name name-style="western"><surname>Gurtman</surname><given-names>A</given-names></name><name name-style="western"><surname>Lockhart</surname><given-names>S</given-names></name><name name-style="western"><surname>Neuzil</surname><given-names>K</given-names></name><name name-style="western"><surname>Mulligan</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>R</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>KA</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Koury</surname><given-names>K</given-names></name><name name-style="western"><surname>Kalina</surname><given-names>W</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>D</given-names></name><name name-style="western"><surname>Fontes-Garfias</surname><given-names>C</given-names></name><name name-style="western"><surname>Shi</surname><given-names>PY</given-names></name><name name-style="western"><surname>T&#252;reci</surname><given-names>&#214;</given-names></name><name name-style="western"><surname>Tompkins</surname><given-names>KR</given-names></name><name name-style="western"><surname>Lyke</surname><given-names>KE</given-names></name><name name-style="western"><surname>Raabe</surname><given-names>V</given-names></name><name name-style="western"><surname>Dormitzer</surname><given-names>PR</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>KU</given-names></name><name name-style="western"><surname>&#350;ahin</surname><given-names>U</given-names></name><name name-style="western"><surname>Gruber</surname><given-names>WC</given-names></name></person-group><article-title>Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><issue>25</issue><fpage>2439</fpage><lpage>2450</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2027906</pub-id><pub-id pub-id-type="pmid">33053279</pub-id><pub-id pub-id-type="pmcid">PMC7583697</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>S</given-names></name><name name-style="western"><surname>Duan</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name><name name-style="western"><surname>You</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W</given-names></name><name name-style="western"><surname>Wan</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S</given-names></name><name name-style="western"><surname>Du</surname><given-names>J</given-names></name><name name-style="western"><surname>Meng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Pan</surname><given-names>A</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shen</surname><given-names>S</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name></person-group><article-title>Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials</article-title><source>JAMA</source><year>2020</year><volume>324</volume><issue>10</issue><fpage>951</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.15543</pub-id><pub-id pub-id-type="pmid">32789505</pub-id><pub-id pub-id-type="pmcid">PMC7426884</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>GF</given-names></name><name name-style="western"><surname>Tan</surname><given-names>W</given-names></name><name name-style="western"><surname>Wu</surname><given-names>G</given-names></name><name name-style="western"><surname>Xu</surname><given-names>M</given-names></name><name name-style="western"><surname>Lou</surname><given-names>Z</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Huang</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ding</surname><given-names>L</given-names></name><name name-style="western"><surname>You</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>G</given-names></name><name name-style="western"><surname>Luo</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>P</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name></person-group><article-title>Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial</article-title><source>Lancet Infect Dis</source><year>2021</year><volume>21</volume><issue>1</issue><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30831-8</pub-id><pub-id pub-id-type="pmid">33069281</pub-id><pub-id pub-id-type="pmcid">PMC7561304</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>G</given-names></name><name name-style="western"><surname>Pan</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chu</surname><given-names>K</given-names></name><name name-style="western"><surname>Han</surname><given-names>W</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tang</surname><given-names>R</given-names></name><name name-style="western"><surname>Yin</surname><given-names>W</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>F</given-names></name></person-group><article-title>Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18&#8211;59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial</article-title><source>Lancet Infect Dis</source><year>2021</year><volume>21</volume><issue>2</issue><fpage>181</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30843-4</pub-id><pub-id pub-id-type="pmid">33217362</pub-id><pub-id pub-id-type="pmcid">PMC7832443</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>FC</given-names></name><name name-style="western"><surname>Guan</surname><given-names>XH</given-names></name><name name-style="western"><surname>Li</surname><given-names>YH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>T</given-names></name><name name-style="western"><surname>Hou</surname><given-names>LH</given-names></name><name name-style="western"><surname>Li</surname><given-names>JX</given-names></name><name name-style="western"><surname>Yang</surname><given-names>BF</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>SP</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wu</surname><given-names>XH</given-names></name><name name-style="western"><surname>Xu</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jia</surname><given-names>SY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>BS</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Qian</surname><given-names>XA</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Pan</surname><given-names>HX</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>HD</given-names></name><name name-style="western"><surname>Deng</surname><given-names>P</given-names></name><name name-style="western"><surname>Gou</surname><given-names>JB</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XW</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name></person-group><article-title>Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial</article-title><source>Lancet</source><year>2020</year><volume>396</volume><issue>10249</issue><fpage>479</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31605-6</pub-id><pub-id pub-id-type="pmid">32702299</pub-id><pub-id pub-id-type="pmcid">PMC7836858</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">Kremsner P, Mann P, Bosch J, Fendel R, Gabor JJ, Kreidenweiss A, Kroidl A, Leroux-Roels I, Leroux-Roels G, Schindler C, Schunk M, Velavan TP, Fotin-Mleczek M, M&#252;ller S, Quintini G, Sch&#246;nborn-Kellenberger O, Vahrenhorst D, Verstraeten T, Walz L, Wolz OO, Oostvogels L. Phase 1 assessment of the safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 in human volunteers. medRxiv 2020: 2020.2011.2009.20228551</mixed-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeyanathan</surname><given-names>M</given-names></name><name name-style="western"><surname>Afkhami</surname><given-names>S</given-names></name><name name-style="western"><surname>Smaill</surname><given-names>F</given-names></name><name name-style="western"><surname>Miller</surname><given-names>MS</given-names></name><name name-style="western"><surname>Lichty</surname><given-names>BD</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Z</given-names></name></person-group><article-title>Immunological considerations for COVID-19 vaccine strategies</article-title><source>Nat Rev Immunol</source><year>2020</year><volume>20</volume><issue>10</issue><fpage>615</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-00434-6</pub-id><pub-id pub-id-type="pmid">32887954</pub-id><pub-id pub-id-type="pmcid">PMC7472682</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M, Quandt J, Bidmon N, Ulges A, Baum A, Pascal K, Maurus D, Brachtendorf S, L&#246;rks V, Sikorski J, Koch P, Hilker R, Becker D, Eller AK, Gr&#252;tzner J, Tonigold M, Boesler C, Rosenbaum C, Heesen L, K&#252;hnle MC, Poran A, Dong JZ, Luxemburger U, Kemmer-Br&#252;ck A, Langer D, Bexon M, Bolte S, Palanche T, Schultz A, Baumann S, Mahiny AJ, Boros G, Reinholz J, Szab&#243; GT, Karik&#243; K, Shi PY, Fontes-Garfias C, Perez JL, Cutler M, Cooper D, Kyratsous CA, Dormitzer PR, Jansen KU, T&#252;reci &#214;. BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans. medRxiv 2020: 2020.2012.2009.20245175</mixed-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jackson</surname><given-names>LA</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Rouphael</surname><given-names>NG</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>PC</given-names></name><name name-style="western"><surname>Makhene</surname><given-names>M</given-names></name><name name-style="western"><surname>Coler</surname><given-names>RN</given-names></name><name name-style="western"><surname>McCullough</surname><given-names>MP</given-names></name><name name-style="western"><surname>Chappell</surname><given-names>JD</given-names></name><name name-style="western"><surname>Denison</surname><given-names>MR</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Pruijssers</surname><given-names>AJ</given-names></name><name name-style="western"><surname>McDermott</surname><given-names>A</given-names></name><name name-style="western"><surname>Flach</surname><given-names>B</given-names></name><name name-style="western"><surname>Doria-Rose</surname><given-names>NA</given-names></name><name name-style="western"><surname>Corbett</surname><given-names>KS</given-names></name><name name-style="western"><surname>Morabito</surname><given-names>KM</given-names></name><name name-style="western"><surname>O&#8217;Dell</surname><given-names>S</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>SD</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>PA</given-names><suffix>2nd</suffix></name><name name-style="western"><surname>Padilla</surname><given-names>M</given-names></name><name name-style="western"><surname>Mascola</surname><given-names>JR</given-names></name><name name-style="western"><surname>Neuzil</surname><given-names>KM</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>H</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Peters</surname><given-names>E</given-names></name><name name-style="western"><surname>Makowski</surname><given-names>M</given-names></name><name name-style="western"><surname>Albert</surname><given-names>J</given-names></name><name name-style="western"><surname>Cross</surname><given-names>K</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>W</given-names></name><name name-style="western"><surname>Pikaart-Tautges</surname><given-names>R</given-names></name><name name-style="western"><surname>Ledgerwood</surname><given-names>JE</given-names></name><name name-style="western"><surname>Graham</surname><given-names>BS</given-names></name><name name-style="western"><surname>Beigel</surname><given-names>JH</given-names></name><collab>mRNA-1273 Study Group</collab></person-group><article-title>An mRNA vaccine against SARS-CoV-2&#8212;preliminary report</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><issue>20</issue><fpage>1920</fpage><lpage>1931</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2022483</pub-id><pub-id pub-id-type="pmid">32663912</pub-id><pub-id pub-id-type="pmcid">PMC7377258</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="other">FDA. Vaccines and Related Biological Products Advisory Committee Meeting, December 10, 2020, FDA Briefing Document. 2020. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.fda.gov/media/144245/download">https://www.fda.gov/media/144245/download</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="other">Plotkin S, Orenstein W, Offit P, Edwards KM. Plotkin&#8217;s Vaccines. Elsevier, 2017</mixed-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pless</surname><given-names>RP</given-names></name><name name-style="western"><surname>Bentsi-Enchill</surname><given-names>AD</given-names></name><name name-style="western"><surname>Duclos</surname><given-names>P</given-names></name></person-group><article-title>Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues</article-title><source>J Infect Dis</source><year>2003</year><volume>187</volume><issue>Suppl 1</issue><fpage>S291</fpage><lpage>S298</lpage><pub-id pub-id-type="doi">10.1086/368049</pub-id><pub-id pub-id-type="pmid">12721928</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>See</surname><given-names>I</given-names></name><name name-style="western"><surname>Su</surname><given-names>JR</given-names></name><name name-style="western"><surname>Lale</surname><given-names>A</given-names></name><name name-style="western"><surname>Woo</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Guh</surname><given-names>AY</given-names></name><name name-style="western"><surname>Shimabukuro</surname><given-names>TT</given-names></name><name name-style="western"><surname>Streiff</surname><given-names>MB</given-names></name><name name-style="western"><surname>Rao</surname><given-names>AK</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>AP</given-names></name><name name-style="western"><surname>Beavers</surname><given-names>SF</given-names></name><name name-style="western"><surname>Durbin</surname><given-names>AP</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>K</given-names></name><name name-style="western"><surname>Miller</surname><given-names>E</given-names></name><name name-style="western"><surname>Harrington</surname><given-names>TA</given-names></name><name name-style="western"><surname>Mba-Jonas</surname><given-names>A</given-names></name><name name-style="western"><surname>Nair</surname><given-names>N</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>DT</given-names></name><name name-style="western"><surname>Talaat</surname><given-names>KR</given-names></name><name name-style="western"><surname>Urrutia</surname><given-names>VC</given-names></name><name name-style="western"><surname>Walker</surname><given-names>SC</given-names></name><name name-style="western"><surname>Creech</surname><given-names>CB</given-names></name><name name-style="western"><surname>Clark</surname><given-names>TA</given-names></name><name name-style="western"><surname>DeStefano</surname><given-names>F</given-names></name><name name-style="western"><surname>Broder</surname><given-names>KR</given-names></name></person-group><article-title>US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021</article-title><source>JAMA</source><year>2021</year><volume>325</volume><issue>24</issue><fpage>2448</fpage><lpage>2456</lpage><pub-id pub-id-type="doi">10.1001/jama.2021.7517</pub-id><pub-id pub-id-type="pmid">33929487</pub-id><pub-id pub-id-type="pmcid">PMC8087975</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scully</surname><given-names>M</given-names></name><name name-style="western"><surname>Singh</surname><given-names>D</given-names></name><name name-style="western"><surname>Lown</surname><given-names>R</given-names></name><name name-style="western"><surname>Poles</surname><given-names>A</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>T</given-names></name><name name-style="western"><surname>Levi</surname><given-names>M</given-names></name><name name-style="western"><surname>Goldblatt</surname><given-names>D</given-names></name><name name-style="western"><surname>Kotoucek</surname><given-names>P</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>W</given-names></name><name name-style="western"><surname>Lester</surname><given-names>W</given-names></name></person-group><article-title>Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>23</issue><fpage>2202</fpage><lpage>2211</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2105385</pub-id><pub-id pub-id-type="pmid">33861525</pub-id><pub-id pub-id-type="pmcid">PMC8112532</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>CC</given-names></name><name name-style="western"><surname>Ko</surname><given-names>WC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>PY</given-names></name><name name-style="western"><surname>Huang</surname><given-names>YC</given-names></name><name name-style="western"><surname>Lee</surname><given-names>PI</given-names></name><name name-style="western"><surname>Hsueh</surname><given-names>PR</given-names></name></person-group><article-title>COVID-19 vaccines and thrombosis with thrombocytopenia syndrome</article-title><source>Expert Rev Vaccines</source><year>2021</year><volume>20</volume><issue>8</issue><fpage>1027</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1080/14760584.2021.1949294</pub-id><pub-id pub-id-type="pmid">34176415</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Johnson &amp; Johnson&#8217;s Janssen COVID-19 vaccine overview and safety. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html">https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="other">National Health Service. Coronavirus (COVID-19) vaccines side effects and safety. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/safety-and-side-effects/">https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/safety-and-side-effects/</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simpson</surname><given-names>CR</given-names></name><name name-style="western"><surname>Shi</surname><given-names>T</given-names></name><name name-style="western"><surname>Vasileiou</surname><given-names>E</given-names></name><name name-style="western"><surname>Katikireddi</surname><given-names>SV</given-names></name><name name-style="western"><surname>Kerr</surname><given-names>S</given-names></name><name name-style="western"><surname>Moore</surname><given-names>E</given-names></name><name name-style="western"><surname>McCowan</surname><given-names>C</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>U</given-names></name><name name-style="western"><surname>Shah</surname><given-names>SA</given-names></name><name name-style="western"><surname>Ritchie</surname><given-names>LD</given-names></name><name name-style="western"><surname>Murray</surname><given-names>J</given-names></name><name name-style="western"><surname>Pan</surname><given-names>J</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>DT</given-names></name><name name-style="western"><surname>Stock</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Wood</surname><given-names>R</given-names></name><name name-style="western"><surname>Chuter</surname><given-names>A</given-names></name><name name-style="western"><surname>Beggs</surname><given-names>J</given-names></name><name name-style="western"><surname>Stagg</surname><given-names>HR</given-names></name><name name-style="western"><surname>Joy</surname><given-names>M</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>RSM</given-names></name><name name-style="western"><surname>de Lusignan</surname><given-names>S</given-names></name><name name-style="western"><surname>Hobbs</surname><given-names>R</given-names></name><name name-style="western"><surname>Lyons</surname><given-names>RA</given-names></name><name name-style="western"><surname>Torabi</surname><given-names>F</given-names></name><name name-style="western"><surname>Bedston</surname><given-names>S</given-names></name><name name-style="western"><surname>O&#8217;Leary</surname><given-names>M</given-names></name><name name-style="western"><surname>Akbari</surname><given-names>A</given-names></name><name name-style="western"><surname>McMenamin</surname><given-names>J</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>C</given-names></name><name name-style="western"><surname>Sheikh</surname><given-names>A</given-names></name></person-group><article-title>First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland</article-title><source>Nat Med</source><year>2021</year><volume>27</volume><issue>7</issue><fpage>1290</fpage><lpage>1297</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01408-4</pub-id><pub-id pub-id-type="pmid">34108714</pub-id><pub-id pub-id-type="pmcid">PMC8282499</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blumenthal</surname><given-names>KG</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>EE</given-names></name><name name-style="western"><surname>Saff</surname><given-names>RR</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>LB</given-names></name><name name-style="western"><surname>Wolfson</surname><given-names>AR</given-names></name><name name-style="western"><surname>Foreman</surname><given-names>RK</given-names></name><name name-style="western"><surname>Hashimoto</surname><given-names>D</given-names></name><name name-style="western"><surname>Banerji</surname><given-names>A</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Anvari</surname><given-names>S</given-names></name><name name-style="western"><surname>Shenoy</surname><given-names>ES</given-names></name></person-group><article-title>Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>13</issue><fpage>1273</fpage><lpage>1277</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2102131</pub-id><pub-id pub-id-type="pmid">33657292</pub-id><pub-id pub-id-type="pmcid">PMC7944952</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelso</surname><given-names>JM</given-names></name></person-group><article-title>Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines</article-title><source>Vaccine</source><year>2021</year><volume>39</volume><issue>6</issue><fpage>865</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2020.12.084</pub-id><pub-id pub-id-type="pmid">33441235</pub-id><pub-id pub-id-type="pmcid">PMC7837118</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baeck</surname><given-names>M</given-names></name><name name-style="western"><surname>Marot</surname><given-names>L</given-names></name><name name-style="western"><surname>Belkhir</surname><given-names>L</given-names></name></person-group><article-title>Delayed large local reactions to mRNA vaccines</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>24</issue><fpage>e98</fpage><pub-id pub-id-type="doi">10.1056/NEJMc2104751</pub-id><pub-id pub-id-type="pmid">33882228</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices&#8212;United States, June 2021. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/mmwr/volumes/70/wr/mm7027e2.htm">https://www.cdc.gov/mmwr/volumes/70/wr/mm7027e2.htm</ext-link> (accessed August 9, 2021)<pub-id pub-id-type="doi" assigning-authority="pmc">10.15585/mmwr.mm7027e2</pub-id><pub-id pub-id-type="pmcid">PMC8312754</pub-id><pub-id pub-id-type="pmid">34237049</pub-id></mixed-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimabukuro</surname><given-names>TT</given-names></name><name name-style="western"><surname>Cole</surname><given-names>M</given-names></name><name name-style="western"><surname>Su</surname><given-names>JR</given-names></name></person-group><article-title>Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US&#8212;December 14, 2020-January 18, 2021</article-title><source>JAMA</source><year>2021</year><volume>325</volume><issue>11</issue><fpage>1101</fpage><lpage>1102</lpage><pub-id pub-id-type="doi">10.1001/jama.2021.1967</pub-id><pub-id pub-id-type="pmid">33576785</pub-id><pub-id pub-id-type="pmcid">PMC8890485</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>ZN</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>YY</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Gao</surname><given-names>HD</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Q</given-names></name><name name-style="western"><surname>Sun</surname><given-names>XX</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>FS</given-names></name><name name-style="western"><surname>Su</surname><given-names>JF</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>YN</given-names></name><name name-style="western"><surname>Shu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XW</given-names></name><name name-style="western"><surname>Yang</surname><given-names>YK</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>YT</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>XM</given-names></name></person-group><article-title>Evaluation of safety of two inactivated COVID-19 vaccines in a large-scale emergency use</article-title><source>Chin J Epidemiol (Zhonghua Liu Xing Bing Xue Za Zhi)</source><year>2021</year><volume>42</volume><issue>6</issue><fpage>977</fpage><lpage>982</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3760/cma.j.cn112338-20210325-00249</pub-id><pub-id pub-id-type="pmid">33874701</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">World Health Organization. Tracking SARS-CoV-2 variants. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/">https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dejnirattisai</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name><name name-style="western"><surname>Supasa</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Mentzer</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Ginn</surname><given-names>HM</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Duyvesteyn</surname><given-names>HME</given-names></name><name name-style="western"><surname>Tuekprakhon</surname><given-names>A</given-names></name><name name-style="western"><surname>Nutalai</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>L&#243;pez-Camacho</surname><given-names>C</given-names></name><name name-style="western"><surname>Slon-Campos</surname><given-names>J</given-names></name><name name-style="western"><surname>Walter</surname><given-names>TS</given-names></name><name name-style="western"><surname>Skelly</surname><given-names>D</given-names></name><name name-style="western"><surname>Costa Clemens</surname><given-names>SA</given-names></name><name name-style="western"><surname>Naveca</surname><given-names>FG</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>V</given-names></name><name name-style="western"><surname>Nascimento</surname><given-names>F</given-names></name><name name-style="western"><surname>Fernandes da Costa</surname><given-names>C</given-names></name><name name-style="western"><surname>Resende</surname><given-names>PC</given-names></name><name name-style="western"><surname>Pauvolid-Correa</surname><given-names>A</given-names></name><name name-style="western"><surname>Siqueira</surname><given-names>MM</given-names></name><name name-style="western"><surname>Dold</surname><given-names>C</given-names></name><name name-style="western"><surname>Levin</surname><given-names>R</given-names></name><name name-style="western"><surname>Dong</surname><given-names>T</given-names></name><name name-style="western"><surname>Pollard</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Knight</surname><given-names>JC</given-names></name><name name-style="western"><surname>Crook</surname><given-names>D</given-names></name><name name-style="western"><surname>Lambe</surname><given-names>T</given-names></name><name name-style="western"><surname>Clutterbuck</surname><given-names>E</given-names></name><name name-style="western"><surname>Bibi</surname><given-names>S</given-names></name><name name-style="western"><surname>Flaxman</surname><given-names>A</given-names></name><name name-style="western"><surname>Bittaye</surname><given-names>M</given-names></name><name name-style="western"><surname>Belij-Rammerstorfer</surname><given-names>S</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>MW</given-names></name><name name-style="western"><surname>Klenerman</surname><given-names>P</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>E</given-names></name><name name-style="western"><surname>Dunachie</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Paterson</surname><given-names>NG</given-names></name><name name-style="western"><surname>Williams</surname><given-names>MA</given-names></name><name name-style="western"><surname>Hall</surname><given-names>DR</given-names></name><name name-style="western"><surname>Hulswit</surname><given-names>RJG</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>TA</given-names></name><name name-style="western"><surname>Fry</surname><given-names>EE</given-names></name><name name-style="western"><surname>Mongkolsapaya</surname><given-names>J</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J</given-names></name><name name-style="western"><surname>Stuart</surname><given-names>DI</given-names></name><name name-style="western"><surname>Screaton</surname><given-names>GR</given-names></name></person-group><article-title>Antibody evasion by the P.1 strain of SARS-CoV-2</article-title><source>Cell</source><year>2021</year><volume>184</volume><issue>11</issue><fpage>2939</fpage><lpage>2954.e9</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.03.055</pub-id><pub-id pub-id-type="pmid">33852911</pub-id><pub-id pub-id-type="pmcid">PMC8008340</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="other">Ikegame S, Siddiquey MNA, Hung CT, Haas G, Brambilla L, Oguntuyo KY, Kowdle S, Vilardo AE, Edelstein A, Perandones C, Kamil JP, Lee B. Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants. medRxiv 2021: 2021.2003.2031.21254660</mixed-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>X</given-names></name><name name-style="western"><surname>Tang</surname><given-names>H</given-names></name><name name-style="western"><surname>McDanal</surname><given-names>C</given-names></name><name name-style="western"><surname>Wagh</surname><given-names>K</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>W</given-names></name><name name-style="western"><surname>Theiler</surname><given-names>J</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Haynes</surname><given-names>BF</given-names></name><name name-style="western"><surname>Sanders</surname><given-names>KO</given-names></name><name name-style="western"><surname>Gnanakaran</surname><given-names>S</given-names></name><name name-style="western"><surname>Hengartner</surname><given-names>N</given-names></name><name name-style="western"><surname>Pajon</surname><given-names>R</given-names></name><name name-style="western"><surname>Smith</surname><given-names>G</given-names></name><name name-style="western"><surname>Glenn</surname><given-names>GM</given-names></name><name name-style="western"><surname>Korber</surname><given-names>B</given-names></name><name name-style="western"><surname>Montefiori</surname><given-names>DC</given-names></name></person-group><article-title>SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines</article-title><source>Cell Host Microbe</source><year>2021</year><volume>29</volume><issue>4</issue><fpage>529</fpage><lpage>539.e3</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2021.03.002</pub-id><pub-id pub-id-type="pmid">33705729</pub-id><pub-id pub-id-type="pmcid">PMC7934674</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>GL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Duan</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Meng</surname><given-names>QC</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>MD</given-names></name><name name-style="western"><surname>Cao</surname><given-names>J</given-names></name><name name-style="western"><surname>Yao</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>KL</given-names></name><name name-style="western"><surname>Cao</surname><given-names>WC</given-names></name><name name-style="western"><surname>Ma</surname><given-names>MJ</given-names></name></person-group><article-title>Susceptibility of circulating SARS-CoV-2 variants to neutralization</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>24</issue><fpage>2354</fpage><lpage>2356</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2103022</pub-id><pub-id pub-id-type="pmid">33822491</pub-id><pub-id pub-id-type="pmcid">PMC8063885</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Nair</surname><given-names>MS</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Iketani</surname><given-names>S</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name><name name-style="western"><surname>Kwong</surname><given-names>PD</given-names></name><name name-style="western"><surname>Graham</surname><given-names>BS</given-names></name><name name-style="western"><surname>Mascola</surname><given-names>JR</given-names></name><name name-style="western"><surname>Chang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Yin</surname><given-names>MT</given-names></name><name name-style="western"><surname>Sobieszczyk</surname><given-names>M</given-names></name><name name-style="western"><surname>Kyratsous</surname><given-names>CA</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>L</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ho</surname><given-names>DD</given-names></name></person-group><article-title>Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7</article-title><source>Nature</source><year>2021</year><volume>593</volume><issue>7857</issue><fpage>130</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03398-2</pub-id><pub-id pub-id-type="pmid">33684923</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="other">Yadav PD, Sapkal GN, Abraham P, Ella R, Deshpande G, Patil DY, Nyayanit DA, Gupta N, Sahay RR, Shete AM, Panda S, Bhargava B, Mohan VK. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. bioRxiv 2021: 2021.2004.2023.441101<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciab411</pub-id><pub-id pub-id-type="pmid">33961693</pub-id></mixed-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shen</surname><given-names>H</given-names></name><name name-style="western"><surname>Huang</surname><given-names>R</given-names></name><name name-style="western"><surname>Tong</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name></person-group><article-title>Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac</article-title><source>Lancet Infect Dis</source><year>2021</year><volume>21</volume><issue>8</issue><fpage>1071</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(21)00287-5</pub-id><pub-id pub-id-type="pmid">34051887</pub-id><pub-id pub-id-type="pmcid">PMC8159188</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>B</given-names></name><name name-style="western"><surname>Dai</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Tan</surname><given-names>W</given-names></name><name name-style="western"><surname>Gao</surname><given-names>GF</given-names></name></person-group><article-title>Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2</article-title><source>Lancet Microbe</source><year>2021</year><volume>2</volume><issue>7</issue><fpage>e285</fpage><pub-id pub-id-type="doi">10.1016/S2666-5247(21)00082-3</pub-id><pub-id pub-id-type="pmid">33870240</pub-id><pub-id pub-id-type="pmcid">PMC8043583</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madhi</surname><given-names>SA</given-names></name><name name-style="western"><surname>Baillie</surname><given-names>V</given-names></name><name name-style="western"><surname>Cutland</surname><given-names>CL</given-names></name><name name-style="western"><surname>Voysey</surname><given-names>M</given-names></name><name name-style="western"><surname>Koen</surname><given-names>AL</given-names></name><name name-style="western"><surname>Fairlie</surname><given-names>L</given-names></name><name name-style="western"><surname>Padayachee</surname><given-names>SD</given-names></name><name name-style="western"><surname>Dheda</surname><given-names>K</given-names></name><name name-style="western"><surname>Barnabas</surname><given-names>SL</given-names></name><name name-style="western"><surname>Bhorat</surname><given-names>QE</given-names></name><name name-style="western"><surname>Briner</surname><given-names>C</given-names></name><name name-style="western"><surname>Kwatra</surname><given-names>G</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>K</given-names></name><name name-style="western"><surname>Aley</surname><given-names>P</given-names></name><name name-style="western"><surname>Bhikha</surname><given-names>S</given-names></name><name name-style="western"><surname>Bhiman</surname><given-names>JN</given-names></name><name name-style="western"><surname>Bhorat</surname><given-names>AE</given-names></name><name name-style="western"><surname>du Plessis</surname><given-names>J</given-names></name><name name-style="western"><surname>Esmail</surname><given-names>A</given-names></name><name name-style="western"><surname>Groenewald</surname><given-names>M</given-names></name><name name-style="western"><surname>Horne</surname><given-names>E</given-names></name><name name-style="western"><surname>Hwa</surname><given-names>SH</given-names></name><name name-style="western"><surname>Jose</surname><given-names>A</given-names></name><name name-style="western"><surname>Lambe</surname><given-names>T</given-names></name><name name-style="western"><surname>Laubscher</surname><given-names>M</given-names></name><name name-style="western"><surname>Malahleha</surname><given-names>M</given-names></name><name name-style="western"><surname>Masenya</surname><given-names>M</given-names></name><name name-style="western"><surname>Masilela</surname><given-names>M</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>S</given-names></name><name name-style="western"><surname>Molapo</surname><given-names>K</given-names></name><name name-style="western"><surname>Moultrie</surname><given-names>A</given-names></name><name name-style="western"><surname>Oelofse</surname><given-names>S</given-names></name><name name-style="western"><surname>Patel</surname><given-names>F</given-names></name><name name-style="western"><surname>Pillay</surname><given-names>S</given-names></name><name name-style="western"><surname>Rhead</surname><given-names>S</given-names></name><name name-style="western"><surname>Rodel</surname><given-names>H</given-names></name><name name-style="western"><surname>Rossouw</surname><given-names>L</given-names></name><name name-style="western"><surname>Taoushanis</surname><given-names>C</given-names></name><name name-style="western"><surname>Tegally</surname><given-names>H</given-names></name><name name-style="western"><surname>Thombrayil</surname><given-names>A</given-names></name><name name-style="western"><surname>van Eck</surname><given-names>S</given-names></name><name name-style="western"><surname>Wibmer</surname><given-names>CK</given-names></name><name name-style="western"><surname>Durham</surname><given-names>NM</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Villafana</surname><given-names>TL</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>S</given-names></name><name name-style="western"><surname>Pollard</surname><given-names>AJ</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>T</given-names></name><name name-style="western"><surname>Moore</surname><given-names>PL</given-names></name><name name-style="western"><surname>Sigal</surname><given-names>A</given-names></name><name name-style="western"><surname>Izu</surname><given-names>A</given-names></name><collab>NGS-SA Group</collab><collab>Wits-VIDA COVID Group</collab></person-group><article-title>Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>20</issue><fpage>1885</fpage><lpage>1898</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2102214</pub-id><pub-id pub-id-type="pmid">33725432</pub-id><pub-id pub-id-type="pmcid">PMC7993410</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>X</given-names></name><name name-style="western"><surname>Tang</surname><given-names>H</given-names></name><name name-style="western"><surname>Pajon</surname><given-names>R</given-names></name><name name-style="western"><surname>Smith</surname><given-names>G</given-names></name><name name-style="western"><surname>Glenn</surname><given-names>GM</given-names></name><name name-style="western"><surname>Shi</surname><given-names>W</given-names></name><name name-style="western"><surname>Korber</surname><given-names>B</given-names></name><name name-style="western"><surname>Montefiori</surname><given-names>DC</given-names></name></person-group><article-title>Neutralization of SARS-CoV-2 variants B.1.429 and B.1.351</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>24</issue><fpage>2352</fpage><lpage>2354</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2103740</pub-id><pub-id pub-id-type="pmid">33826819</pub-id><pub-id pub-id-type="pmcid">PMC8063884</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Dcosta</surname><given-names>BM</given-names></name><name name-style="western"><surname>Samanovic</surname><given-names>MI</given-names></name><name name-style="western"><surname>Mulligan</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Landau</surname><given-names>NR</given-names></name><name name-style="western"><surname>Tada</surname><given-names>T</given-names></name></person-group><article-title>B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies</article-title><source>mBio</source><year>2021</year><volume>12</volume><issue>4</issue><fpage>e0138621</fpage><pub-id pub-id-type="doi">10.1128/mBio.01386-21</pub-id><pub-id pub-id-type="pmid">34311587</pub-id><pub-id pub-id-type="pmcid">PMC8406170</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Casner</surname><given-names>RG</given-names></name><name name-style="western"><surname>Nair</surname><given-names>MS</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Cerutti</surname><given-names>G</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Kwong</surname><given-names>PD</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>L</given-names></name><name name-style="western"><surname>Ho</surname><given-names>DD</given-names></name></person-group><article-title>Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization</article-title><source>Cell Host Microbe</source><year>2021</year><volume>29</volume><issue>5</issue><fpage>747</fpage><lpage>751.e4</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2021.04.007</pub-id><pub-id pub-id-type="pmid">33887205</pub-id><pub-id pub-id-type="pmcid">PMC8053237</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xia</surname><given-names>H</given-names></name><name name-style="western"><surname>Zou</surname><given-names>J</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>SC</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>KA</given-names></name><name name-style="western"><surname>Cai</surname><given-names>H</given-names></name><name name-style="western"><surname>Cutler</surname><given-names>M</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>D</given-names></name><name name-style="western"><surname>Muik</surname><given-names>A</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>KU</given-names></name><name name-style="western"><surname>Sahin</surname><given-names>U</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X</given-names></name><name name-style="western"><surname>Dormitzer</surname><given-names>PR</given-names></name><name name-style="western"><surname>Shi</surname><given-names>PY</given-names></name></person-group><article-title>BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants</article-title><source>Nature</source><year>2021</year><volume>596</volume><issue>7871</issue><fpage>273</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03693-y</pub-id><pub-id pub-id-type="pmid">34111888</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wall</surname><given-names>EC</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Harvey</surname><given-names>R</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>G</given-names></name><name name-style="western"><surname>Warchal</surname><given-names>S</given-names></name><name name-style="western"><surname>Sawyer</surname><given-names>C</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>R</given-names></name><name name-style="western"><surname>Hobson</surname><given-names>P</given-names></name><name name-style="western"><surname>Hatipoglu</surname><given-names>E</given-names></name><name name-style="western"><surname>Ngai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>S</given-names></name><name name-style="western"><surname>Nicod</surname><given-names>J</given-names></name><name name-style="western"><surname>Goldstone</surname><given-names>R</given-names></name><name name-style="western"><surname>Ambrose</surname><given-names>K</given-names></name><name name-style="western"><surname>Hindmarsh</surname><given-names>S</given-names></name><name name-style="western"><surname>Beale</surname><given-names>R</given-names></name><name name-style="western"><surname>Riddell</surname><given-names>A</given-names></name><name name-style="western"><surname>Gamblin</surname><given-names>S</given-names></name><name name-style="western"><surname>Howell</surname><given-names>M</given-names></name><name name-style="western"><surname>Kassiotis</surname><given-names>G</given-names></name><name name-style="western"><surname>Libri</surname><given-names>V</given-names></name><name name-style="western"><surname>Williams</surname><given-names>B</given-names></name><name name-style="western"><surname>Swanton</surname><given-names>C</given-names></name><name name-style="western"><surname>Gandhi</surname><given-names>S</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>DLV</given-names></name></person-group><article-title>Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination</article-title><source>Lancet</source><year>2021</year><volume>397</volume><issue>10292</issue><fpage>2331</fpage><lpage>2333</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)01290-3</pub-id><pub-id pub-id-type="pmid">34090624</pub-id><pub-id pub-id-type="pmcid">PMC8175044</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>A</given-names></name><name name-style="western"><surname>Koch</surname><given-names>M</given-names></name><name name-style="western"><surname>Wu</surname><given-names>K</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>G</given-names></name><name name-style="western"><surname>Oestreicher</surname><given-names>J</given-names></name><name name-style="western"><surname>Legault</surname><given-names>H</given-names></name><name name-style="western"><surname>Stewart-Jones</surname><given-names>GBE</given-names></name><name name-style="western"><surname>Colpitts</surname><given-names>T</given-names></name><name name-style="western"><surname>Pajon</surname><given-names>R</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>H</given-names></name><name name-style="western"><surname>Carfi</surname><given-names>A</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>DK</given-names></name></person-group><article-title>Serum neutralizing activity of mRNA-1273 against SARS-CoV-2 variants</article-title><source>J Virol</source><year>2021</year><volume>95</volume><issue>23</issue><fpage>e0131321</fpage><pub-id pub-id-type="doi">10.1128/JVI.01313-21</pub-id><pub-id pub-id-type="pmid">34549975</pub-id><pub-id pub-id-type="pmcid">PMC8577347</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sapkal</surname><given-names>GN</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>PD</given-names></name><name name-style="western"><surname>Sahay</surname><given-names>RR</given-names></name><name name-style="western"><surname>Deshpande</surname><given-names>G</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>N</given-names></name><name name-style="western"><surname>Nyayanit</surname><given-names>DA</given-names></name><name name-style="western"><surname>Patil</surname><given-names>DY</given-names></name><name name-style="western"><surname>Shete</surname><given-names>AM</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>P</given-names></name><name name-style="western"><surname>Panda</surname><given-names>S</given-names></name><name name-style="western"><surname>Bhargava</surname><given-names>B</given-names></name></person-group><article-title>Neutralization of Delta variant with sera of Covishield&#8482; vaccinees and COVID-19 recovered vaccinated individuals</article-title><source>J Travel Med</source><year>2021</year><volume>28</volume><issue>7</issue><fpage>taab119</fpage><pub-id pub-id-type="doi">10.1093/jtm/taab119</pub-id><pub-id pub-id-type="pmid">34343316</pub-id><pub-id pub-id-type="pmcid">PMC8385819</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emary</surname><given-names>KRW</given-names></name><name name-style="western"><surname>Golubchik</surname><given-names>T</given-names></name><name name-style="western"><surname>Aley</surname><given-names>PK</given-names></name><name name-style="western"><surname>Ariani</surname><given-names>CV</given-names></name><name name-style="western"><surname>Angus</surname><given-names>B</given-names></name><name name-style="western"><surname>Bibi</surname><given-names>S</given-names></name><name name-style="western"><surname>Blane</surname><given-names>B</given-names></name><name name-style="western"><surname>Bonsall</surname><given-names>D</given-names></name><name name-style="western"><surname>Cicconi</surname><given-names>P</given-names></name><name name-style="western"><surname>Charlton</surname><given-names>S</given-names></name><name name-style="western"><surname>Clutterbuck</surname><given-names>EA</given-names></name><name name-style="western"><surname>Collins</surname><given-names>AM</given-names></name><name name-style="western"><surname>Cox</surname><given-names>T</given-names></name><name name-style="western"><surname>Darton</surname><given-names>TC</given-names></name><name name-style="western"><surname>Dold</surname><given-names>C</given-names></name><name name-style="western"><surname>Douglas</surname><given-names>AD</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>CJA</given-names></name><name name-style="western"><surname>Ewer</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Flaxman</surname><given-names>AL</given-names></name><name name-style="western"><surname>Faust</surname><given-names>SN</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>DM</given-names></name><name name-style="western"><surname>Feng</surname><given-names>S</given-names></name><name name-style="western"><surname>Finn</surname><given-names>A</given-names></name><name name-style="western"><surname>Folegatti</surname><given-names>PM</given-names></name><name name-style="western"><surname>Fuskova</surname><given-names>M</given-names></name><name name-style="western"><surname>Galiza</surname><given-names>E</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>AL</given-names></name><name name-style="western"><surname>Green</surname><given-names>CM</given-names></name><name name-style="western"><surname>Green</surname><given-names>CA</given-names></name><name name-style="western"><surname>Greenland</surname><given-names>M</given-names></name><name name-style="western"><surname>Hallis</surname><given-names>B</given-names></name><name name-style="western"><surname>Heath</surname><given-names>PT</given-names></name><name name-style="western"><surname>Hay</surname><given-names>J</given-names></name><name name-style="western"><surname>Hill</surname><given-names>HC</given-names></name><name name-style="western"><surname>Jenkin</surname><given-names>D</given-names></name><name name-style="western"><surname>Kerridge</surname><given-names>S</given-names></name><name name-style="western"><surname>Lazarus</surname><given-names>R</given-names></name><name name-style="western"><surname>Libri</surname><given-names>V</given-names></name><name name-style="western"><surname>Lillie</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Ludden</surname><given-names>C</given-names></name><name name-style="western"><surname>Marchevsky</surname><given-names>NG</given-names></name><name name-style="western"><surname>Minassian</surname><given-names>AM</given-names></name><name name-style="western"><surname>McGregor</surname><given-names>AC</given-names></name><name name-style="western"><surname>Mujadidi</surname><given-names>YF</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Plested</surname><given-names>E</given-names></name><name name-style="western"><surname>Pollock</surname><given-names>KM</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>H</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>Song</surname><given-names>R</given-names></name><name name-style="western"><surname>Snape</surname><given-names>MD</given-names></name><name name-style="western"><surname>Sutherland</surname><given-names>RK</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>EC</given-names></name><name name-style="western"><surname>Toshner</surname><given-names>M</given-names></name><name name-style="western"><surname>Turner</surname><given-names>DPJ</given-names></name><name name-style="western"><surname>Vekemans</surname><given-names>J</given-names></name><name name-style="western"><surname>Villafana</surname><given-names>TL</given-names></name><name name-style="western"><surname>Williams</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Hill</surname><given-names>AVS</given-names></name><name name-style="western"><surname>Lambe</surname><given-names>T</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name><name name-style="western"><surname>Voysey</surname><given-names>M</given-names></name><name name-style="western"><surname>Ramasamy</surname><given-names>MN</given-names></name><name name-style="western"><surname>Pollard</surname><given-names>AJ</given-names></name><collab>COVID-19 Genomics UK consortium</collab><collab>AMPHEUS Project</collab><collab>Oxford COVID-19 Vaccine Trial Group</collab></person-group><article-title>Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial</article-title><source>Lancet</source><year>2021</year><volume>397</volume><issue>10282</issue><fpage>1351</fpage><lpage>1362</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00628-0</pub-id><pub-id pub-id-type="pmid">33798499</pub-id><pub-id pub-id-type="pmcid">PMC8009612</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abu-Raddad</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Chemaitelly</surname><given-names>H</given-names></name><name name-style="western"><surname>Butt</surname><given-names>AA</given-names></name><collab>National Study Group for COVID-19 Vaccination</collab></person-group><article-title>Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants</article-title><source>N Engl J Med</source><year>2021</year><volume>385</volume><issue>2</issue><fpage>187</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2104974</pub-id><pub-id pub-id-type="pmid">33951357</pub-id><pub-id pub-id-type="pmcid">PMC8117967</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chemaitelly</surname><given-names>H</given-names></name><name name-style="western"><surname>Yassine</surname><given-names>HM</given-names></name><name name-style="western"><surname>Benslimane</surname><given-names>FM</given-names></name><name name-style="western"><surname>Al Khatib</surname><given-names>HA</given-names></name><name name-style="western"><surname>Tang</surname><given-names>P</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>MR</given-names></name><name name-style="western"><surname>Malek</surname><given-names>JA</given-names></name><name name-style="western"><surname>Coyle</surname><given-names>P</given-names></name><name name-style="western"><surname>Ayoub</surname><given-names>HH</given-names></name><name name-style="western"><surname>Al Kanaani</surname><given-names>Z</given-names></name><name name-style="western"><surname>Al Kuwari</surname><given-names>E</given-names></name><name name-style="western"><surname>Jeremijenko</surname><given-names>A</given-names></name><name name-style="western"><surname>Kaleeckal</surname><given-names>AH</given-names></name><name name-style="western"><surname>Latif</surname><given-names>AN</given-names></name><name name-style="western"><surname>Shaik</surname><given-names>RM</given-names></name><name name-style="western"><surname>Abdul Rahim</surname><given-names>HF</given-names></name><name name-style="western"><surname>Nasrallah</surname><given-names>GK</given-names></name><name name-style="western"><surname>Al Kuwari</surname><given-names>MG</given-names></name><name name-style="western"><surname>Al Romaihi</surname><given-names>HE</given-names></name><name name-style="western"><surname>Al-Thani</surname><given-names>MH</given-names></name><name name-style="western"><surname>Al Khal</surname><given-names>A</given-names></name><name name-style="western"><surname>Butt</surname><given-names>AA</given-names></name><name name-style="western"><surname>Bertollini</surname><given-names>R</given-names></name><name name-style="western"><surname>Abu-Raddad</surname><given-names>LJ</given-names></name></person-group><article-title>mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar</article-title><source>Nat Med</source><year>2021</year><volume>27</volume><issue>9</issue><fpage>1614</fpage><lpage>1621</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01446-y</pub-id><pub-id pub-id-type="pmid">34244681</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shinde</surname><given-names>V</given-names></name><name name-style="western"><surname>Bhikha</surname><given-names>S</given-names></name><name name-style="western"><surname>Hoosain</surname><given-names>Z</given-names></name><name name-style="western"><surname>Archary</surname><given-names>M</given-names></name><name name-style="western"><surname>Bhorat</surname><given-names>Q</given-names></name><name name-style="western"><surname>Fairlie</surname><given-names>L</given-names></name><name name-style="western"><surname>Lalloo</surname><given-names>U</given-names></name><name name-style="western"><surname>Masilela</surname><given-names>MSL</given-names></name><name name-style="western"><surname>Moodley</surname><given-names>D</given-names></name><name name-style="western"><surname>Hanley</surname><given-names>S</given-names></name><name name-style="western"><surname>Fouche</surname><given-names>L</given-names></name><name name-style="western"><surname>Louw</surname><given-names>C</given-names></name><name name-style="western"><surname>Tameris</surname><given-names>M</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N</given-names></name><name name-style="western"><surname>Goga</surname><given-names>A</given-names></name><name name-style="western"><surname>Dheda</surname><given-names>K</given-names></name><name name-style="western"><surname>Grobbelaar</surname><given-names>C</given-names></name><name name-style="western"><surname>Kruger</surname><given-names>G</given-names></name><name name-style="western"><surname>Carrim-Ganey</surname><given-names>N</given-names></name><name name-style="western"><surname>Baillie</surname><given-names>V</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>T</given-names></name><name name-style="western"><surname>Lombard Koen</surname><given-names>A</given-names></name><name name-style="western"><surname>Lombaard</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Mngqibisa</surname><given-names>R</given-names></name><name name-style="western"><surname>Bhorat</surname><given-names>AE</given-names></name><name name-style="western"><surname>Benad&#233;</surname><given-names>G</given-names></name><name name-style="western"><surname>Lalloo</surname><given-names>N</given-names></name><name name-style="western"><surname>Pitsi</surname><given-names>A</given-names></name><name name-style="western"><surname>Vollgraaff</surname><given-names>PL</given-names></name><name name-style="western"><surname>Luabeya</surname><given-names>A</given-names></name><name name-style="western"><surname>Esmail</surname><given-names>A</given-names></name><name name-style="western"><surname>Petrick</surname><given-names>FG</given-names></name><name name-style="western"><surname>Oommen-Jose</surname><given-names>A</given-names></name><name name-style="western"><surname>Foulkes</surname><given-names>S</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>K</given-names></name><name name-style="western"><surname>Thombrayil</surname><given-names>A</given-names></name><name name-style="western"><surname>Fries</surname><given-names>L</given-names></name><name name-style="western"><surname>Cloney-Clark</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>C</given-names></name><name name-style="western"><surname>Albert</surname><given-names>G</given-names></name><name name-style="western"><surname>Faust</surname><given-names>E</given-names></name><name name-style="western"><surname>Plested</surname><given-names>JS</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>A</given-names></name><name name-style="western"><surname>Neal</surname><given-names>S</given-names></name><name name-style="western"><surname>Cho</surname><given-names>I</given-names></name><name name-style="western"><surname>Glenn</surname><given-names>GM</given-names></name><name name-style="western"><surname>Dubovsky</surname><given-names>F</given-names></name><name name-style="western"><surname>Madhi</surname><given-names>SA</given-names></name><collab>2019nCoV-501 Study Group</collab></person-group><article-title>Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><issue>20</issue><fpage>1899</fpage><lpage>1909</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2103055</pub-id><pub-id pub-id-type="pmid">33951374</pub-id><pub-id pub-id-type="pmcid">PMC8091623</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hitchings</surname><given-names>MDT</given-names></name><name name-style="western"><surname>Ranzani</surname><given-names>OT</given-names></name><name name-style="western"><surname>Torres</surname><given-names>MSS</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>SB</given-names></name><name name-style="western"><surname>Almiron</surname><given-names>M</given-names></name><name name-style="western"><surname>Said</surname><given-names>R</given-names></name><name name-style="western"><surname>Borg</surname><given-names>R</given-names></name><name name-style="western"><surname>Schulz</surname><given-names>WL</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>RD</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>PV</given-names></name><name name-style="western"><surname>de Castro</surname><given-names>DB</given-names></name><name name-style="western"><surname>Sampaio</surname><given-names>VS</given-names></name><name name-style="western"><surname>de Albuquerque</surname><given-names>BC</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>TCA</given-names></name><name name-style="western"><surname>Fraxe</surname><given-names>SHH</given-names></name><name name-style="western"><surname>da Costa</surname><given-names>CF</given-names></name><name name-style="western"><surname>Naveca</surname><given-names>FG</given-names></name><name name-style="western"><surname>Siqueira</surname><given-names>AM</given-names></name><name name-style="western"><surname>de Ara&#250;jo</surname><given-names>WN</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>JR</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>DAT</given-names></name><name name-style="western"><surname>Ko</surname><given-names>AI</given-names></name><name name-style="western"><surname>Croda</surname><given-names>J</given-names></name></person-group><article-title>Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: a test-negative case-control study</article-title><source>Lancet Reg Health Am</source><year>2021</year><volume>1</volume><fpage>100025</fpage><pub-id pub-id-type="pmid">34386791</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lana.2021.100025</pub-id><pub-id pub-id-type="pmcid">PMC8310555</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Motozono</surname><given-names>C</given-names></name><name name-style="western"><surname>Toyoda</surname><given-names>M</given-names></name><name name-style="western"><surname>Zahradnik</surname><given-names>J</given-names></name><name name-style="western"><surname>Saito</surname><given-names>A</given-names></name><name name-style="western"><surname>Nasser</surname><given-names>H</given-names></name><name name-style="western"><surname>Tan</surname><given-names>TS</given-names></name><name name-style="western"><surname>Ngare</surname><given-names>I</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>I</given-names></name><name name-style="western"><surname>Uriu</surname><given-names>K</given-names></name><name name-style="western"><surname>Kosugi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yue</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>R</given-names></name><name name-style="western"><surname>Ito</surname><given-names>J</given-names></name><name name-style="western"><surname>Torii</surname><given-names>S</given-names></name><name name-style="western"><surname>Yonekawa</surname><given-names>A</given-names></name><name name-style="western"><surname>Shimono</surname><given-names>N</given-names></name><name name-style="western"><surname>Nagasaki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Minami</surname><given-names>R</given-names></name><name name-style="western"><surname>Toya</surname><given-names>T</given-names></name><name name-style="western"><surname>Sekiya</surname><given-names>N</given-names></name><name name-style="western"><surname>Fukuhara</surname><given-names>T</given-names></name><name name-style="western"><surname>Matsuura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Schreiber</surname><given-names>G</given-names></name><collab>Genotype to Phenotype Japan G2P-Japan Consortium</collab><name name-style="western"><surname>Ikeda</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakagawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Ueno</surname><given-names>T</given-names></name><name name-style="western"><surname>Sato</surname><given-names>K</given-names></name></person-group><article-title>SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity</article-title><source>Cell Host Microbe</source><year>2021</year><volume>29</volume><issue>7</issue><fpage>1124</fpage><lpage>1136.e11</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2021.06.006</pub-id><pub-id pub-id-type="pmid">34171266</pub-id><pub-id pub-id-type="pmcid">PMC8205251</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><mixed-citation publication-type="other">Kumar V, Singh J, Hasnain SE, Sundar D. Possible link between higher transmissibility of B.1.617 and B.1.1.7 variants of SARS-CoV-2 and increased structural stability of its spike protein and hACE2 affinity. bioRxiv 2021: 2021.2004.2029.441933<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22179131</pub-id><pub-id pub-id-type="pmcid">PMC8431609</pub-id><pub-id pub-id-type="pmid">34502041</pub-id></mixed-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frampton</surname><given-names>D</given-names></name><name name-style="western"><surname>Rampling</surname><given-names>T</given-names></name><name name-style="western"><surname>Cross</surname><given-names>A</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>H</given-names></name><name name-style="western"><surname>Heaney</surname><given-names>J</given-names></name><name name-style="western"><surname>Byott</surname><given-names>M</given-names></name><name name-style="western"><surname>Scott</surname><given-names>R</given-names></name><name name-style="western"><surname>Sconza</surname><given-names>R</given-names></name><name name-style="western"><surname>Price</surname><given-names>J</given-names></name><name name-style="western"><surname>Margaritis</surname><given-names>M</given-names></name><name name-style="western"><surname>Bergstrom</surname><given-names>M</given-names></name><name name-style="western"><surname>Spyer</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Miralhes</surname><given-names>PB</given-names></name><name name-style="western"><surname>Grant</surname><given-names>P</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>S</given-names></name><name name-style="western"><surname>Valerio</surname><given-names>C</given-names></name><name name-style="western"><surname>Mangera</surname><given-names>Z</given-names></name><name name-style="western"><surname>Prabhahar</surname><given-names>T</given-names></name><name name-style="western"><surname>Moreno-Cuesta</surname><given-names>J</given-names></name><name name-style="western"><surname>Arulkumaran</surname><given-names>N</given-names></name><name name-style="western"><surname>Singer</surname><given-names>M</given-names></name><name name-style="western"><surname>Shin</surname><given-names>GY</given-names></name><name name-style="western"><surname>Sanchez</surname><given-names>E</given-names></name><name name-style="western"><surname>Paraskevopoulou</surname><given-names>SM</given-names></name><name name-style="western"><surname>Pillay</surname><given-names>D</given-names></name><name name-style="western"><surname>McKendry</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mirfenderesky</surname><given-names>M</given-names></name><name name-style="western"><surname>Houlihan</surname><given-names>CF</given-names></name><name name-style="western"><surname>Nastouli</surname><given-names>E</given-names></name></person-group><article-title>Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study</article-title><source>Lancet Infect Dis</source><year>2021</year><volume>21</volume><issue>9</issue><fpage>1246</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(21)00170-5</pub-id><pub-id pub-id-type="pmid">33857406</pub-id><pub-id pub-id-type="pmcid">PMC8041359</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davies</surname><given-names>NG</given-names></name><name name-style="western"><surname>Jarvis</surname><given-names>CI</given-names></name><collab>CMMID COVID-19 Working Group</collab><name name-style="western"><surname>Edmunds</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Jewell</surname><given-names>NP</given-names></name><name name-style="western"><surname>Diaz-Ordaz</surname><given-names>K</given-names></name><name name-style="western"><surname>Keogh</surname><given-names>RH</given-names></name></person-group><article-title>Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7</article-title><source>Nature</source><year>2021</year><volume>593</volume><issue>7858</issue><fpage>270</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03426-1</pub-id><pub-id pub-id-type="pmid">33723411</pub-id><pub-id pub-id-type="pmcid">PMC9170116</pub-id></element-citation></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="other">Our World in Data. COVID-19 vaccine doses administered, May 16, 2021. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://ourworldinData.org/grapher/cumulative-covid-vaccinations?time=latest&amp;country=~OWID_WRL">https://ourworldinData.org/grapher/cumulative-covid-vaccinations?time=latest&amp;country=~OWID_WRL</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="other">abc NEWS. Canada vaccine panel recommends 4 months between COVID doses. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://abcnews.go.com/International/wireS-tory/canada-vaccine-panel-recommends-months-covid-doses-76239947">https://abcnews.go.com/International/wireS-tory/canada-vaccine-panel-recommends-months-covid-doses-76239947</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR102"><label>102.</label><mixed-citation publication-type="other">National Health Service. Letter to chief executives of all NHS trusts and foundation trusts. 2020. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/12/C0994-System-letter-COVID-19-vaccination-deployment-planning-30-December-2020.pdf">https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/12/C0994-System-letter-COVID-19-vaccination-deployment-planning-30-December-2020.pdf</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR103"><label>103.</label><mixed-citation publication-type="other">Republic World. Turkey to extend interval between doses of the vaccine. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.republicworld.com/world-news/rest-of-the-world-news/turkey-to-extend-interval-between-doses-of-the-vaccine.html">https://www.republicworld.com/world-news/rest-of-the-world-news/turkey-to-extend-interval-between-doses-of-the-vaccine.html</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR104"><label>104.</label><mixed-citation publication-type="other">Moderna. Storing vaccine vials. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.modernatx.com/covid19vaccine-eua/providers/storage-handling">https://www.modernatx.com/covid19vaccine-eua/providers/storage-handling</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR105"><label>105.</label><mixed-citation publication-type="other">Precision Vaccinations. BioNTech-Pfizer COVID-19 vaccine. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.precisionvaccinations.com/vaccines/biontech-pfizer-covid-19-vaccine">https://www.precisionvaccinations.com/vaccines/biontech-pfizer-covid-19-vaccine</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jarrett</surname><given-names>C</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>R</given-names></name><name name-style="western"><surname>O&#8217;Leary</surname><given-names>M</given-names></name><name name-style="western"><surname>Eckersberger</surname><given-names>E</given-names></name><name name-style="western"><surname>Larson</surname><given-names>HJ</given-names></name><collab>SAGE Working Group on Vaccine Hesitancy</collab></person-group><article-title>Strategies for addressing vaccine hesitancy&#8212;a systematic review</article-title><source>Vaccine</source><year>2015</year><volume>33</volume><issue>34</issue><fpage>4180</fpage><lpage>4190</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2015.04.040</pub-id><pub-id pub-id-type="pmid">25896377</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Razai</surname><given-names>MS</given-names></name><name name-style="western"><surname>Chaudhry</surname><given-names>UAR</given-names></name><name name-style="western"><surname>Doerholt</surname><given-names>K</given-names></name><name name-style="western"><surname>Bauld</surname><given-names>L</given-names></name><name name-style="western"><surname>Majeed</surname><given-names>A</given-names></name></person-group><article-title>Covid-19 vaccination hesitancy</article-title><source>BMJ</source><year>2021</year><volume>373</volume><issue>1138</issue><fpage>n1138</fpage><pub-id pub-id-type="doi">10.1136/bmj.n1138</pub-id><pub-id pub-id-type="pmid">34016653</pub-id></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freeman</surname><given-names>D</given-names></name><name name-style="western"><surname>Loe</surname><given-names>BS</given-names></name><name name-style="western"><surname>Yu</surname><given-names>LM</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>J</given-names></name><name name-style="western"><surname>Chadwick</surname><given-names>A</given-names></name><name name-style="western"><surname>Vaccari</surname><given-names>C</given-names></name><name name-style="western"><surname>Shanyinde</surname><given-names>M</given-names></name><name name-style="western"><surname>Harris</surname><given-names>V</given-names></name><name name-style="western"><surname>Waite</surname><given-names>F</given-names></name><name name-style="western"><surname>Rosebrock</surname><given-names>L</given-names></name><name name-style="western"><surname>Petit</surname><given-names>A</given-names></name><name name-style="western"><surname>Vanderslott</surname><given-names>S</given-names></name><name name-style="western"><surname>Lewandowsky</surname><given-names>S</given-names></name><name name-style="western"><surname>Larkin</surname><given-names>M</given-names></name><name name-style="western"><surname>Innocenti</surname><given-names>S</given-names></name><name name-style="western"><surname>Pollard</surname><given-names>AJ</given-names></name><name name-style="western"><surname>McShane</surname><given-names>H</given-names></name><name name-style="western"><surname>Lambe</surname><given-names>S</given-names></name></person-group><article-title>Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial</article-title><source>Lancet Public Health</source><year>2021</year><volume>6</volume><issue>6</issue><fpage>e416</fpage><lpage>e427</lpage><pub-id pub-id-type="doi">10.1016/S2468-2667(21)00096-7</pub-id><pub-id pub-id-type="pmid">33991482</pub-id><pub-id pub-id-type="pmcid">PMC8116130</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><mixed-citation publication-type="other">Wu K, Choi A, Koch M, Ma L, Hill A, Nunna N, Huang W, Oestreicher J, Colpitts T, Bennett H, Legault H, Paila Y, Nestorova B, Ding B, Pajon R, Miller JM, Leav B, Carfi A, McPhee R, Edwards DK. Preliminary analysis of safety and immunogenicity of a SARS-CoV-2 variant vaccine booster. medRxiv 2021: 2021.2005.2005.21256716</mixed-citation></ref><ref id="CR110"><label>110.</label><mixed-citation publication-type="other">U.S. Food and Drug Administration. Emergency use authorization for vaccines to prevent COVID-19. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-vaccines-prevent-covid-19">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-vaccines-prevent-covid-19</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR111"><label>111.</label><mixed-citation publication-type="other">Medicines and Healthcare products Regulatory Agency. Guidance on strain changes in authorised COVID-19 vaccines. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.gov.uk/government/publications/access-consortium-guidance-on-strain-changes-in-authorised-covid-19-vaccines/guidance-on-strain-changes-in-authorised-covid-19-vaccines">https://www.gov.uk/government/publications/access-consortium-guidance-on-strain-changes-in-authorised-covid-19-vaccines/guidance-on-strain-changes-in-authorised-covid-19-vaccines</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR112"><label>112.</label><mixed-citation publication-type="other">European Medicines Agency. Reflection paper on the regulatory requirements for vaccines intended to provide protection against variant strain(s) of SARS-CoV-2. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-regulatory-requirements-vaccines-intended-provide-protection-against-variant_en.pdf">https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-regulatory-requirements-vaccines-intended-provide-protection-against-variant_en.pdf</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR113"><label>113.</label><mixed-citation publication-type="other">Therapeutic Goods Administration. TGA adopts Access Consortium guidance for fast-tracking authorisations of modified COVID-19 vaccines for variants. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.tga.gov.au/tga-adopts-access-consortium-guidance-fast-tracking-authorisations-modified-covid-19-vaccines-variants">https://www.tga.gov.au/tga-adopts-access-consortium-guidance-fast-tracking-authorisations-modified-covid-19-vaccines-variants</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR114"><label>114.</label><mixed-citation publication-type="other">McGill COVID19 Vaccine Tracker Team. COVID-19 vaccine tracker. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://covid19.trackvaccines.org/vaccines/">https://covid19.trackvaccines.org/vaccines/</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR115"><label>115.</label><mixed-citation publication-type="other">AstraZeneca. AZD1222 US phase III primary analysis confirms safety and efficacy. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.astrazeneca.com/mediacentre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html">https://www.astrazeneca.com/mediacentre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR116"><label>116.</label><mixed-citation publication-type="other">ClinicalTrial.gov. Phase III trial of a COVID-19 vaccine of adenovirus vector in adults 18 years old and above. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04526990?term=vaccine&amp;cond=covid-19&amp;draw=6#wrapper">https://clinicaltrials.gov/ct2/show/NCT04526990?term=vaccine&amp;cond=covid-19&amp;draw=6#wrapper</ext-link> (accessed August 9, 2021)</mixed-citation></ref><ref id="CR117"><label>117.</label><mixed-citation publication-type="other">Jongeneelen M, Kaszas K, Veldman D, Huizingh J, van der Vlugt R, Schouten T, Zuijdgeest D, Uil T, van Roey G, Guimera N, Navis M, Bos R, le Gars M, Sadoff J, Muchene L, Juraszek J, Langedijk JPM, Vogels R, Custers J, Schuitemaker H, Brandenburg B. Ad26. COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern. bioRxiv 2021: 2021.2007.2001.450707</mixed-citation></ref><ref id="CR118"><label>118.</label><mixed-citation publication-type="other">Novavax. Novavax confirms high levels of efficacy against original and variant COVID-19 strains in United Kingdom and South Africa Trials. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://ir.novavax.com/news-releases/news-release-details/novavax-confirms-high-levels-efficacy-against-original-and-0">https://ir.novavax.com/news-releases/news-release-details/novavax-confirms-high-levels-efficacy-against-original-and-0</ext-link> (accessed August 9, 2021)</mixed-citation></ref></ref-list></back></article></pmc-articleset>